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1. Abstract 
Severe sepsis and septic shock are major healthcare problems and, although there has 
been extensive research, remain the major causes for mortality in intensive care units. 
For a faster detection of sepsis causing pathogens a DNA microarray-based assay was 
established which allows the identification of 30 different bloodstream infection rele-
vant pathogens from whole blood samples. 
During this work an internal control was implemented in order to monitor each working 
step of the microarray protocol, including DNA extraction, PCR and labeling reactions as 
well as hybridization. Microarray data allow a semi-quantitative analysis of DNA concen-
trations. However, internal control sequences are needed for normalization and to con-
trol obtained data, as signal intensities underlie considerable fluctuations. In order to 
validate the results of microarray quantification, a real-time PCR protocol was estab-
lished. 
Most PCR based analyses have the shortcoming to only generate information about the 
presence of bacteria but not about the physiological activity of those bacteria. This 
problem can be solved by detecting RNA instead of DNA since most RNA is quickly de-
graded and is only detectable in actively metabolizing cells. 
Considering these facts a screening of the viability status of diverse pathogens, based on 
microarray technology was realized. Therefore the protocol for the identification of pa-
thogens causing bloodstream infections applying a DNA chip was optimized to allow the 
detection of RNA. Several RNA amplification techniques were tested, among them a 
method called NASBA (nucleic acid sequence-based amplification). Besides this an 
mRNA detection protocol for diverse housekeeping genes was established to evaluate 
the possibility for quantification of mRNA. 
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Zusammenfassung 
Schwere Sepsis und septischer Schock verursachen gravierende Probleme in Spitälern 
und Ambulanzen. Trotz intensiver Forschung auf dem Gebiet, bleibt Sepsis eine der 
häufigsten Todesursachen in der Intensivmedizin. Für die rasche Identifizierung von 
Sepsis verursachenden Pathogenen, wurde ein DNA Microarray entwickelt. Dieser 
ermöglicht die Identifikation von 30 verschiedenen Erregern von Blutstrominfektionen 
direkt aus Vollblut. 
In dieser Arbeit wurde eine interne Kontrolle etabliert um die Effizienz eines jeden 
Teilschrittes des Microarray Protokolls zu kontrollieren. Dies inkludiert die DNA 
Extraktion aus Vollblut, PCR- und Labeling-Reaktionen sowie die Hybridisierung. Darüber 
hinaus ermöglichen diese Ergebnisse eine semiquantitiative Analyse von DNA 
Konzentrationen. Die Signalintensitäten der internen Kontrolle werden für eine 
Normalisierung und Überwachung der Daten von pathogen-spezifischen Sonden 
benötigt, da diese erheblichen Schwankungen unterliegen können. Ein real-time PCR 
Protokoll wurde etabliert, um die Ergebnisse der Microarray basierten Quantifizierung 
zu evaluieren. 
PCR basierte Methoden geben nur Ergebnisse über ein Vorhandensein von bakterieller 
DNA, jedoch nicht über die physiologische Aktivität der Erreger. Anhand der Detektion 
von mRNA anstelle von DNA kann dieses Problem gelöst werden, da RNA sehr schnell 
abgebaut wird und nur in Zellen mit aktivem Metabolismus nachweisbar ist. 
Aus diesem Grund wurde ein Screeningverfahren basierend auf Microarray Technologie 
getestet, welches der Bestimmung des Viabilitätsstatus verschiedener Pathogene 
mittels mRNA Detektion dient. Um eine RNA Detektion zu ermöglichen, wurde das 
Protokoll für den Identifikations-Chip für Sepsiserreger adaptiert. Hierfür wurden 
verschiedene RNA Amplifikationstechniken getestet, inklusive einer Methode namens 
NASBA (nucleic acid sequence-based amplification). Eine Quantifizierung der mRNA 
verschiedener Haushaltsgene wurde ebenfalls etabliert. 
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2. Introduction 
2.1 Medical Microbiology 
Severe sepsis and septic shock are prominent healthcare problems which affect millions 
of people worldwide each year [Dellinger et al., 2008]. Despite an extensive research for 
about two decades, sepsis remains a major cause of mortality in intensive care units, 
with mortality rates ranging from 30 to 70% [Riedemann et al., 2003b]. Levy et al. stated 
that severe sepsis is accounting for 150.000 deaths per year in Europe, thus making it 
the most common cause of death in noncoronary critical care units. Treatment costs for 
severe sepsis amount up to €7.6 billion in the EU and sepsis incidences are rising at a 
rate of 1.5 % per year due to population aging and an increase in immunecompromised 
people [Hunter, 2006]. 
The first signs of sepsis are unspecific and often unclear. Within hours patients with no 
obvious signs of disease can develop severe symptoms that, left untreated, are ultimate-
ly leading to death. By definition a patient with sepsis suffers an actual or assumed in-
fection going along with symptoms indicating a SIRS (systemic inflammatory response 
syndrome) [Rivers et al., 2005]. SIRS criteria, defined in the 1992 statement from the 
ACCP/SCCM Consensus Conference, are listed in table 1. SIRS is considered to be 
present when a patient shows at least two of the in 1992 stated criteria [Levy et al., 
2003]. However, SIRS being a host response can be caused by an infection but also by 
non-infectious conditions and therefore does not specifically indicate sepsis [Levy et al., 
2003]. Non-infectious conditions stimulating a SIRS are for example trauma, malignancy 
and surgeries such as coronary artery bypass grafting [Kerbaul et al., 2004; Hunter, 
2006]. 
 
SIRS criteria, as defined by the ACCP/SCCM Consensus Conference 
Body temperature: higher than 38°C or lower than 36°C 
Heart rate: over 90 beats per minute 
Respiratory rate: higher than 20 breaths per minute or a PaCO2 lower 
than 32 mmHg 
Leukocyte count: higher than 12,000 cells/µl or lower than 4,000 cells/µl 
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Severe sepsis is defined as sepsis accompanied by a dysfunction of an organ (e.g. the 
hematologic system, the pulmonary system, the renal system) [Levy et al., 2003]. 
Patients suffering from septic shock experience a state of falling blood pressures (arteri-
al hypotension) and require vasopressor support [Rivers et al., 2005; Levy et al., 2003]. 
Hypotension is identified by a systolic blood pressure lower than 90 mmHg or a mean 
arterial pressure lower than 65 mmHg [Rivers et al., 2005]. 
Until recently sepsis was considered an over the top immune response [Hotchkiss and 
Karl, 2003]. Inflammation normally helps to eliminate microorganisms from an origin of 
infection. However, in sepsis patients inflammation becomes a systemic syndrome 
showing numerous symptoms (see SIRS definition) [Decker et al., 2004]. Accounting to 
these assumptions, clinical trials conducted during the past 40 years were mainly fo-
cused on anti-inflammatory agents [Riedemann et al., 2003a]. However, none of these 
studies showed significant improvement in survival of septic patients [Hotchkiss and 
Karl, 2003; Riedemann et al., 2003a]. 
One applied target for therapy was tumor necrosis factor alpha (TNF-α). It was shown 
that the administration of high amounts of endotoxins or bacteria in animal models, 
lead to high levels of circulating cytokines like TNF-α [Hotchkiss and Karl, 2003]. Addi-
tionally injection of TNF-α into animals evoked symptoms comparable to those of sepsis 
[Riedemann et al., 2003a]. These animals died from an endotoxic shock and passive im-
munization against TNF-α increased survival rates [Hotchkiss and Karl, 2003; Riedemann 
et al., 2003a]. However, because therapy approaches in humans failed, it was consi-
dered that these animal models do not mirror the disease pattern of sepsis patients 
[Hotchkiss and Karl, 2003]. 
Fast detection of pathogens is critical for survival of patients with bloodstream infec-
tions and septicaemia. A large scale study of Kumar et al., including 2.731 patients suf-
fering from septic shock, showed that over the first 6 hrs after the onset of recurrent or 
Table 1: Clinical findings indicating the presence of a SIRS (systemic inflammatory 
response syndrome) as defined by the ACCP/SCCM Consensus Conference in 1992 
[Levy et al., 2003; Rivers et al., 2005]. 
9 
persistent hypotension, a critical marker of septic shock, mean survival rates decreased 
by 7.6 % with each hour passed without initiation of effective antimicrobial therapy. The 
time span before effective treatment and associated survival rates are illustrated in fig-
ure 1. While 82.7 % of patients survived if the time span between first evidence of hypo-
tension and administration of effective antimicrobials was 30 minutes, the survival rate 
was only 42.0 % if it took more than five hours for patients to receive the appropriate 
treatment [Kumar et al., 2006].  
 
2.2 Clinical Diagnostic: Traditional microbiological techniques 
Blood cultures are currently the standard technique for the detection and identification 
of bloodstream infection inducing pathogens in patients with fever [Peters et al., 2004; 
Wiesinger et al., 2007]. Since Libman in 1906 first published guidelines on the realization 
of over 700 blood cultures, the techniques have evolved leading to fully automated sys-
tems for the detection of microbial growth [Peters et al., 2004; Libman, 1906]. Today 
automated systems, such as BacT/Alert (Biomérieux, Lyon Area, France) and BAC-
TEC9240 (BD, Franklin Lakes, USA) are the standard cultivation procedures in clinical 
diagnostics [Wiesinger et al., 2007]. 
Figure 1: Survival rates of patients who received effective antimicrobial treatment after 
0 to over 36 hours after showing first signs of hypotension (a critical marker of septic 
shock) are illustrated in this figure. The y-axis represents the fraction of total patients 
while the x-axis represents the time passed after hypotension onset. Black bars indicate 
survival rates while grey bars represent the fraction of patients receiving effective 
treatment at a given time point [Kumar et al., 2006]. 
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Both systems detect an increase in CO2 levels, an indicator for microbial growth, using 
continuously monitored fluorescent (BACTEC9240) or colorimetric (BacT/Alert) sensors 
[Shigei et al., 1995; Nolte et al., 1993; Kocoglu et al., 2005]. 
Automated blood culture systems have considerably reduced the time needed to detect 
positive blood cultures [Shigei et al., 1995]. However, as blood culture systems are de-
pendent on microbial growth rates, results are obtained after a minimum of 24 hours 
[Wiesinger et al., 2007]. Other limitations of blood cultures are the often poor sensitivity 
for slow growing and fastidious pathogens and the reduction in sensitivity when blood 
samples are taken after the onset of antimicrobial therapy [Peters et al., 2004]. 
Therefore, nucleic acid-based molecular techniques for the identification of microorgan-
isms become more and more influential [Peters et al., 2004]. 
 
2.3 Clinical diagnostic: Nucleic acid-based methods 
Molecular biology was revolutionized by the invention of the polymerase chain reaction 
(PCR) by Mullis in 1984 [Mullis et al., 1986]. In the following years detection of nearly 
every clinically relevant bacterial pathogen was allowed via new PCR-based assays [Mo-
thershed and Whitney, 2006]. Also, in the late 1980s other nucleic acid amplification 
methods were developed, including ligation-mediated amplification [Wu and Wallace, 
1989] and transcription-based amplification [Kwoh et al., 1989] [Monis and Giglio, 
2006]. However, these methods never gained equal acceptation for diagnostic applica-
tions than PCR methods. This might arise from the superiority of PCR applications re-
garding simplicity and cost-effectiveness [Monis and Giglio, 2006]. 
The main advantage of nucleic acid-based assays is their shorter time to results com-
pared to conventional blood culturing methods, since they are not dependent on bac-
terial growth [Mothershed and Whitney, 2006]. Also, lower detection limits and the de-
tection of specific microorganisms, including non-cultivable or fastidious microorgan-
isms, can be accomplished by the use of nucleic acid-based techniques. However, there 
are some disadvantages such as false positive signals due to contamination or the lack 
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of viability information due to the solely detection of pathogen specific nucleic acids 
[Mothershed and Whitney, 2006]. 
Several nucleic acid based methods applied in clinical diagnostics are briefly presented 
in the following chapters and further detailed information is given on methods used in 
this work. 
 
2.3.1 Nested PCR  
Nested PCR is a conventional PCR method with initial target amplification with an outer 
primer pair followed by a second amplification with an inner primer pair. Because of the 
second amplification nested PCR shows an improved sensitivity [Mothershed and Whit-
ney, 2006; Ratcliff et al., 2002]. 
 
2.3.2 Ligase chain reaction (LCR) 
LCR is based on the ligation of two adjacent oligonucleotide primers that hybridize to 
the target DNA [Wiedmann et al., 1994]. It is based on a thermostabile ligase, which will 
only ligate the two probes if they exactly match the template DNA, making LCR a candi-
date method for the detection of single nucleotide polymorphisms (SNPs) [Wiedmann et 
al., 1994; Monis and Giglio, 2006]. The two primers are positioned in a way that the SNP 
overlaps with the 3’ end nucleotide of the upstream primer. If the sequences match, the 
ligase will join the two primers. In order to exponentially amplify the product of the liga-
tion, a second pair of primers is used. In a cycling reaction the ligation products can 
serve as a template for the next ligation reaction, which leads to doubling of the ligation 
product in each cycle, similar to PCR amplification [Wiedmann et al., 1994]. LCR is a 
promising technology especially for SNP detection and for use in microarrays, despite 
some recently reported problems with reproducibility [Monis and Giglio, 2006]. A com-
mercially available test for Clamydia detection based on LCR was taken off the market in 
2003 because of problems concerning negative controls and non-repeating positives 
[Mothershed and Whitney, 2006; Monis and Giglio, 2006]. 
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2.3.3 Strand displacement amplification (SDA) 
SDA is an isothermal amplification technique for DNA [Walker et al., 1992]. It is rather 
complicated as it requires two sets of primers (which bind adjacent to each other), two 
enzymes and a modified deoxynucleotide (dATPS) [Monis and Giglio, 2006]. The initial 
steps of the reaction include the primers binding in positions flanking the target se-
quence. The inner primer pair (closest to the target sequence) have restriction enzyme 
recognition sites on their 5’ ends. The four primers are then extended by an exonuclease 
deficient DNA polymerase (Klenow fragment). Products of the outer primer pair displace 
the products of the inner primer pair, which then serve as template for further exten-
sions. Extension and displacement reactions finally produce hemiphosphorothioate 
dsDNA with restriction recognition sites on one or on both ends, respectively (see fig-
ure 2) [Walker et al., 1992]. These hemiphosphorothioate restriction recognition sites 
are cut by the restriction enzyme, generating a single stranded nick. The nick is then 
repaired by DNA polymerase, generating a new strand of DNA which displaces the 
strand downstream to the nick. The process is exponential because the displaced strand 
serves as target for new primers (of the inner primer pair) promoting further extensions 
[Monis and Giglio, 2006; Walker et al., 1992]. SDA allows the production of 109 copies of 
target DNA per reaction and is the basis for some commercially available detection 
tests, for example BDProbeTec (Becton Dickinson) [Mothershed and Whitney, 2006]. 
5’ 3’ 
5’ 3’ 
3’ 5’ 
5’ 3’ 
3’ 
5’ 
3’ 
5’ 
3’ 
5’ 
3’ 
5’ 
5’ 
3’ 
3’ 5’ 
3’ 
5’ 
3’ 5’ 
Figure 2: Extension and displacement reactions in SDA generating hemiphosphoro-
thoiate dsDNA with restriction recognitions sites on one of both ends, respectively. 
Red lines: outer primer pair; blue and green lines: inner primer pair with restriction 
recognition site (bold green lines). 
Alignment of primers to 
ssDNA 
New alignment of primers to 
products of first extension 
and displacement reactions 
Final products after several 
rounds of primer extension 
and displacement reactions: 
dsDNA with restrictions rec-
ognitions sites on one or 
both ends 
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2.3.4 Hybrid capture tests 
The Hybrid Capture (HC) assays from Digene (Gaithersburg, MD), aim for signal amplifi-
cation instead of target amplification. The HC1 assay introduced in 1995 aimed to detect 
14 human papilloma virus (HPV) types, and was improved in a second generation of hy-
brid capture assays (HC2) [Vernick and Steigman, 2003]. The concept is the hybridization 
of pathogenic DNA to a specific RNA probe to form a RNA/DNA hybrid. This hybrid is 
then captured by specific antibodies that bind it to a solid substrate, and is subsequently 
detected by a second antibody carrying the alkaline phosphatase enzyme. Alkaline 
phosphatase cleaves the phosphate moiety from a specific luminescent substrate which 
then emits light. Signal amplification is achieved because many antibodies bind to one 
RNA/DNA hybrid [Mothershed and Whitney, 2006]. 
 
2.3.5 Fluorescence in situ hybridization (FISH) 
Fluorescence in situ hybridization applying fluorescently labeled rRNA probes can detect 
and identify microorganisms in complex samples such as blood culture and tissue within 
a few hours. Even multiple species can be detected in one assay when the specific 
probes are labeled with different dyes. The procedure involves fixing of the microbial 
cells with suitable chemicals, permeabilizing the cells and finally hybridizing the sample 
on a glass slide or in solution with the 15-25 nucleotide long probes. After a washing 
step fluorescence detection is realized by fluorescence microscopy or flow-cytometry 
[Wagner et al., 2003; Mothershed and Whitney, 2006]. Specific FISH probes were devel-
oped for the identification of many bacteria species, including Pseudomonas aeruginosa 
[Jansen et al., 2000], Staphylococcus spp. [Kempf et al., 2000], Streptococcus spp. [Tre-
besius et al., 2001] and several others. 
 
2.3.6 Mass spectrometry 
Mass spectrometry is an analytical technique that ionizes target molecules by firing elec-
trons at them. The mass/charge ratio of the generated charged molecules is then ana-
lyzed and a molecular signature is generated [Mothershed and Whitney, 2006]. Impor-
tant information about biomolecules such as their molecular composition and structure 
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can be obtained by mass spectrometry. However, at the beginning, analysis of nucleic 
acids was limited to oligonucleotides shorter than ~20 bp, due to inefficient generation 
of gas-phase ions of larger samples [Meng et al., 2004; Gut, 2004]. New ionization tech-
niques like electrospray ionization (ESI) and matrixassisted laser desorption/ionization 
(MALDI) solved that problem and revolutionized analysis of nucleic acids by mass spec-
trometry [Meng et al., 2004]. MALDI is fast and in combination with time-of-flight analy-
sis (MALDI-TOF) especially suited for analysis of complex molecules [Gut, 2004]. There-
fore mass spectrometry with MALDI-TOF ionizations is considered a valuable tool for 
bacterial detection in clinical diagnostics [Mothershed and Whitney, 2006]. 
 
2.3.7 Real-time PCR and RT-PCR 
During real-time PCR the DNA amplification and detection is carried out simultaneously. 
The advantages to conventional PCR based amplification are lower duration and a re-
duction of the risk for contamination, since both steps are performed in a closed system 
without the need for an agarose gel electrophoresis [Peters et al., 2004; Rosey et al., 
2007; Tobler et al., 2006]. Real-time PCR methods are based on the generation of a fluo-
rescent signal in each cycle which can be measured directly and simultaneously [Peters 
et al., 2004]. Detection chemistries can be divided into two groups: intercalating dyes 
which bind to dsDNA (eg SYBR® Green, ethidium bromide, SYTO9) and probe based de-
tection systems (eg TaqMan® probes, 3’ MGB probes, molecular beacons) [Monis and 
Giglio, 2006]. The detection methods applying TaqMan® probes and SYBR Green® will be 
explained in more detail, because these two methods are among the most important 
ones. 
2.3.7.1 SYBR® Green Real-time PCR: 
SYBR® green is a molecule which fluoresces when bound to dsDNA. With each PCR cycle 
more dsDNA is generated, leading to an increase in fluorescence by SYBR® green. Be-
cause no probes are needed, SYBR® green is a less expensive method to detect DNA 
amplification [Mackay et al., 2002]. Amongst its disadvantages is that SYBR® green de-
tects any dsDNA, including primer-dimers and non-specific amplification products. How-
ever, melting curve analysis allows the discrimination of specific product from nonspe-
cific products or primer-dimers [Mothershed and Whitney, 2006]. 
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2.3.7.2 TaqMan® Real-time PCR: 
This detection method relies upon fluorescence resonance energy transfer (FRET), be-
tween a fluorophore and a non-fluorescent quencher [Mackay et al., 2002]. The Taq-
Man® probe is a 20-30 bp long oligonucleotide, which is specific to a certain sequence 
within the desired amplicon. This probe carries the reporter fluorescent dye (e.g. TAM) 
at the 5’ end and the quencher (e.g. TAMRA) at the 3’ end [Peters et al., 2004; Gibson et 
al., 1996]. On the complete TaqMan® probe the fluorescent dye and the quencher mo-
lecules lie in close proximity, therefore fluorescent emission of the dye is extinguished 
by the quencher [Mackey et al., 1992; Gibson et al., 1996]. During PCR the Taq Polyme-
rase extends the new DNA strand and displaces and hydrolyses the probe via its 5’-3’ 
exonuclease activity. This releases the reporter dye from the quencher, generating a 
fluorescent signal [Peters et al., 2004; Mackay et al., 2002]. In TaqMan® assays no melt-
ing curve analysis can be performed to validate the amplification of a specific product, 
therefore it is especially important to test the specificity of primer/probe combinations 
[Monis and Giglio, 2006]. 
The kinetics of PCR ought to be known to analyze real-time PCR results. When fluores-
cence intensity is plotted against the cycle number in an ideal real-time PCR reaction, a 
sigmoid growth curve is generated, which can be seen in figure 3 [Mackay et al., 2002]. 
PCR amplification can be divided into four stages. It starts with a pre-log phase where 
amplification is not yet fully efficient. This phase is followed by the logarithmic phase, in 
which the DNA copy number ideally doubles every cycle [Higuchi et al., 1993]. Then the 
reaction slows due to product accumulation and limitation of primers and enzyme. This 
phase is called the transition phase, which finally leads to the plateau phase in which 
little or no further amplification of DNA takes place [Mackay et al., 2002].  
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Early cycles of amplification are not detectable, because the specific fluorescence can-
not be distinguished from background fluorescence. The cycle at which the specific fluo-
rescence first reaches significant levels, is called the threshold cycle and is dependent on 
the starting copy number of DNA [Mackay et al., 2002]. Samples containing more DNA 
will reach significant fluorescence intensity at an earlier cycle than samples containing 
only small amounts of DNA. Quantification is possible by relating the threshold cycles of 
unknown samples to the values of a standard curve [Peters et al., 2004]. 
Therefore the DNA amplification of real-time PCR needs to be highly efficient. Reliable 
quantification can only be achieved when the target sequence is logarithmically ampli-
fied, which is a prerequisite for the comparison of different samples. Logarithmic ampli-
fication is achieved when the amount of DNA doubles every cycle. Therefore after n 
cycles the amount of DNA is the 2n fold of the starting amount. To calculate the efficien-
cy of the PCR a dilution series is amplified. In a ½-dilution series the single steps should 
Figure 3: Cycle numbers were plotted against fluorescence intensity in real-time PCR. Lo-
garithmic (LP), transition (TP) and plateau phases (PP) are indicated. At the dash dotted 
line the measured fluorescence intensity goes beyond a background level and is now 
clearly detectable. This cycle number (black arrow) is called the threshold cycle, which is 
an important value in real-time PCR. The threshold line is set by the user and should lie 
within the logarithmic phase of the PCR reaction. 
The threshold cycle number depends on the initial DNA copy number, thus making real-
time PCR an effective method to quantify DNA. Different starting amounts of DNA produce 
a shift in the sigmoidal growth curve either to the left (less starting DNA) or to the right 
(more starting DNA) leading to a change in threshold cycles. 
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differ by 1 cycle and 1/10-dilutions should differ by ~3.3 cycles (because 23.3=10). The 
final copy number can be calculated applying the following formula:  
 
with n representing the number of thermal cycles. 
 
2.3.8 Microarray technology 
DNA microarray technology allows the parallel and high throughput analysis of thou-
sands of genes, or the simultaneous identification of many different bacteria and viruses 
in a single assay [Borel et al., 2008; Loy and Bodrossy, 2006]. 
Only 10 years ago analysis of gene expression was a slow, low throughput process, 
where only one gene at a time was investigated typically by northern blot analysis [Har-
diman, 2004]. The post-genomic era, with publicly available sequences of whole ge-
nomes, drastically changed science and scientific methods. Microarrays, which allow a 
highly parallel analysis of gene expression, perfectly represent that post-genomic era of 
high throughput science [Hardiman, 2004]. 
2.3.8.1 What is it and how does it work? 
A microarray is a solid substrate (e.g. a glass slide) to which the capture DNA, either in 
form of oligonucleotides or the cDNA of whole genes, are immobilized by covalent lin-
kage [Bryant et al., 2004]. Protein microarrays, which apply proteins instead of DNA as 
capture molecules, usually consist of immobilized antibodies or antigens. DNA is trans-
ferred onto the array surface in form of microscopic spots, each consisting of thousands 
of oligonucleotide copies. Nucleic acids in the test sample (the target DNA) are labeled 
(e.g. via fluorescence dyes) and then hybridized to the capture DNA on the chip. After 
hybridization of the target DNA, spots with complementary probes will emit fluores-
cence, which can be detected by specific scanners. 
In a two color analysis the samples are taken under different circumstances and are la-
beled with two different fluorescent dyes, which allow sample discrimination on the 
chip (e.g. one testing sample and one comparison or standard sample). Two different 
fluorophores are widely used for labeling of DNA during microarray experiments. They 
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are named Cy3 and Cy5 and emit light at 570 nm (green part of the spectrum) and 670 
nm (red part of the spectrum), respectively. When sample DNA is labeled with both dyes 
and hybridized to one spot it appears yellow, meaning that respective sequence is 
present in both samples. Up and down regulated genes in the samples can be identified 
with this system based on the color of the spots [Hardiman, 2004]. Figure 4 shows a 
DNA microarray hybridized to fluorophore-labeled E. coli DNA (green spots). 
 
2.3.8.2 Fabrication of microarrays 
Different types of microarrays can be distinguished by their spotting method. There are 
contact (e.g. pins) and non-contact (piezoelectric and photolithographic) techniques, 
which differ in their mode of probe deposition. Contact printing is widely used and in-
cludes methods such as contact pin printing and microstamping. There are several non-
contact printing methods and most of them originated from the printing industry. Ink-
jetting methods are thermal ink jet, microsolenoids, piezoelectric, and acoustic ink print-
ing [Hsieh et al., 2004]. Other non-contact printing methods include photochemistry-
based methods (e.g. photolithographic spotting), laser writing and electrospray deposi-
tion [Barbulovic-Nad et al., 2006]. Contact pin printing, piezoelectric printing and photo-
lithographic spotting will be discussed in detail. 
Contact pin printing: Microarrays are produced by printing presynthesized ssDNA (or 
dsDNA) onto glass slides [Kato-Maeda et al., 2001]. Especially full-length cDNAs but also 
oligonucleotide probes are used for this platform. A robot arm which carries a set of 
pins (see figure 5), first dips the pins into the probe suspension and then prints the 
probes onto specific locations on the glass slides. Glass slides with different surfaces 
(amino-propylsilane reactive groups, aldehyde reactive groups, epoxy reactive groups) 
Figure 4: The microarray results of a hybridization with labeled E. coli DNA are shown in 
this figure. Green spots: E. coli DNA labeled with the dye Atto532, hybridized to chip 
probes. Red spots: hybridization control DNA labeled with Cy5. 
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are available and the chemistry by which the DNA is linked to the slide depends on the 
surface. Aldehyde slides have aldehyde groups as reactive group on the glass surface. 
DNA probes are 5’ terminally amino modified and bind to the aldehyde groups by form-
ing a Schiff base, thus covalently linking the DNA to the glass slide. Spotted DNA micro-
arrays can be produced “in house” also by research institutions. 
 
Piezoelectric printing: Most inkjet printers produce heat to vaporize the ink and create a 
bubble. By expanding this bubble a tiny amount of ink is pushed out of the nozzle and 
onto the paper. This technique, however, cannot be used for biological material as the 
heat would damage proteins and DNA [Hsieh et al., 2004]. In piezoelectric systems a 
small piezoelectric element is located near each nozzle. When a small electric charge is 
applied to the piezo ceramics it causes a change in shape [Hsieh et al., 2004] or gene-
rates an acoustic wave [Nagaraj et al., 2008] which leads to displacement of a small 
droplet of sample from the nozzle. The advantages of this method are the variable and 
small droplet size (tens to hundreds of picoliters) and the high-ejection rate [Hsieh et al., 
2004; Nagaraj et al., 2008]. 
Photolithographic spotting: By photolithography production, arrays with extremely high 
information content can be produced. They are constructed by directly synthesizing 
25 bp (Affimetrix) to 60 bp (Agilent) long oligonucleotides in situ onto the solid substrate 
[Hardiman, 2004]. A schematic representation of the process is shown in figure 6. A sol-
id support is covered with light-sensitive masking agents. Upon illumination through a 
photolithographic mask, selected areas are deprotected and reactive hydroxyl groups 
are exposed. 5’-hydroxyl protected nucleotides then couple to the deprotected areas, 
Figure 5: A picture of a microarray 
spotter head with pins [Kato-Maeda 
et al., 2001]. 
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followed by capping and oxidation steps. The process is repeated with a different mask 
to deprotect other areas and gradually “build” a sequence one nucleotide after the oth-
er [Lipshutz et al., 1999; Pease et al., 1994]. Such high density oligonucleotide arrays, 
however, cannot be produced in house and are only available from commercial suppli-
ers [Kato-Maeda et al., 2001]. Especially noteworthy are GeneChips from Affimetrix. The 
company pioneered the field of microarray technology and their GeneChips are quite 
popular due to their high number of probes, a good level of reproducibility and because 
they are delivered ready for use [Hardiman, 2004]. Other vendors of microarray plat-
forms are Agilent and Amersham Biosciences. 
 
2.3.8.3 Analysis of microarray data 
Microarray experiments produce an enormous amount of data. Normalization of micro-
array data is a crucial step in making them comparable. Normalization generally requires 
a set of probes that are expected to give constant signals (e.g. housekeeping genes) 
[Bryant et al., 2004]. However, if such probes are not available a quantile normalization 
approach can be chosen [Wiesinger et al., 2007]. Normalization of other factors, such as 
background fluorescence, variation in DNA amount in different spots, differences be-
tween slides, is done by specialized software [Bryant et al., 2004]. 
A 
B 
Figure 6: Representation of the photolithographic spotting technique. A: graphi-
cal representation of the spotting process; the orange boxes represent protec-
tions groups; for further information about the spotting process see text; B: 
schematic of the lamp, mask and array in photolithographic spotting [Lipshutz et 
al., 1999] 
21 
Clustering of data allows the classification and grouping of genes based on similarities 
and differences in their expression patterns, which is represented by different signal 
intensities after hybridization. All different clustering algorithms have in common the 
assumption that genes with similar expression pattern are likely to engage in related 
processes [Ferea and Brown, 1999]. There are a variety of clustering methods, each hav-
ing its strengths and weaknesses, which can be divided into the following two groups: 
designated supervised and unsupervised clustering. Supervised clustering uses refer-
ence vectors (based on external biological or clinical knowledge) while in unsupervised 
clustering no such vectors are applied [Eisen et al., 1998]. 
The patterns created by the clustering software can be represented in expression or 
heat maps, that allow the data to be observed in an intuitive manner [Ferea and Brown, 
1999; Eisen et al., 1998]. A heat map is a two-dimensional graphical representation of 
the data, in which for example probes and hybridizations correspond to columns and 
rows, respectively. Also colors are used to illustrate values quantitatively and qualita-
tively [Eisen et al., 1998; Wiesinger et al., 2007]. An example of a heat map is shown in 
figure 7. 
Figure 7: Example of a heat map, drawn after a hierarchical clustering. Data were ob-
tained by a parallel identification of different pathogens using microarray technology. 
Probes are printed in columns and hybridizations are printed in rows. The color corres-
ponds to signal intensities where the color blue represents high signal values and the 
color red represents low or no signal values. Image by Wiesinger et al., 2007. 
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2.3.8.4 Applications 
One of the most important applications for microarrays is gene expression monitoring. 
In order to understand gene function, its expression is investigated in manner of time 
and reason [Lipshutz et al., 1999]. To address these questions, the expression of large 
numbers of genes needs to be observed in different tissues at several times and under 
different circumstances. Especially oligonucleotide arrays with millions of probes are 
well suited for this task [Lipshutz et al., 1999]. 
Since many pathogenic genomes are sequenced and the human genome project is com-
pleted, new methods for the identification of pathogen host interactions are available 
[Bryant et al., 2004]. DNA Microarrays are ideal to study those interactions because they 
allow the parallel, high-throughput detection of thousands of genes [Bodrossy and Ses-
sitsch, 2004; Bryant et al., 2004].  
Microarrays also have big potential in many other areas of microbiology including the 
field of clinical diagnostics. By a careful selection of probe sets, several thousand micro-
bial strains and also species, genera and families can be detected and distinguished in a 
single assay [Bodrossy and Sessitsch, 2004]. For infection diagnostic applications the 
main advantage of new microarray techniques are speed and accuracy. Reliable results 
are obtained after maximal 6 hours with further potential for reduction of total analysis 
time. 
An ideal target gene for probe design is the 16S rRNA gene. It is present in all bacteria 
and encodes the same product in all bacteria. The 16S rRNA gene consists of many dif-
ferent domains. Some of them are highly conserved with almost identical sequences in 
different species and others have variable sequences. These inspired Woese in 1987 to 
consider rRNA the “ultimate molecular chronometer” [Barken et al., 2007]. Figure 8 
shows a schematic representation of the 16Sr RNA. Probes against highly conserved 
regions of the 16S rRNA gene will detect almost any bacterial species, while probes 
against variable regions of the gene are specific for a few or even only one bacterial spe-
cies. Conserved regions are also the optimal target for universal primers in order to am-
plify DNA from unknown species. 
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On this concept Wiesinger et al., 2007 established a DNA microarray-based assay which 
allows the identification of 30 different bloodstream infection relevant pathogens (bac-
teria and fungi) from whole blood samples. On the DNA chip 96 probes specific for se-
quences within constant and variable regions of the 16S rDNA gene (for fungi the 18S 
rDNA gene) were spotted, allowing species-specific identification of human pathogens. 
This concept is considered to allow fast detection of sepsis or septicemia causing micro-
bes also in clinical practice. 
 
2.4 Assessment of bacterial viability 
Traditionally used culture methods may be inferior to PCR based methods in terms of 
handling-time and sensitivity but they only detect viable organisms [Birch et al., 2001]. 
The new generation of PCR based methods detect bacteria at higher sensitivity. Howev-
er, they do not provide any information about the viability status of the cells. Inactive 
bacteria, such as dormant cells and also dead cells with their DNA not yet degraded, are 
all detected in the same way as active cells [Bodrossy et al., 2006]. 
It was believed that DNA would be degraded more rapidly than any other cellular com-
ponents in dead cells, making intact DNA a good indicator for the viability of bacteria. 
Later it was shown that the correlation between cell viability and detection of DNA is 
Figure 8: A schematic representation of the 
secondary structure of the 16S rRNA of E. coli. 
The colors represent the different domains of 
the rRNA. Image by Garrett und Grisham, 1995 
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actually very poor [Keer and Birch, 2003]. Masters et al. found that in actively killed 
cells, DNA can be detected even after long periods of time, when plate counts have long 
declined to zero [Masters et al., 1994]. 
Messenger RNA (mRNA) is a very labile molecule with a half-life of seconds to minutes 
and was proposed to be a better target for analyzing bacterial viability. Ribosomal RNA 
(rRNA), which has a longer half-life than mRNA was also tested as a marker for viability. 
In these test a good correlation between detection of rRNA and viability of the cells was 
found. However, mRNA was found to be a better indicator for bacterial viability than 
rRNA [Keer and Birch, 2003]. 
Both the rRNA per cell and the RNA:DNA ratio strongly correlate with the cells’ growth 
rate. This positive correlation has been shown for a number of bacteria including E. coli, 
A. aerogenes, S. typhimurium and some resin acid-degrading bacteria [Muttray and 
Mohn, 1999; Kemp et al., 1993]. The chemical composition of the growth medium only 
influences DNA and RNA quantities of a cell by affecting its growth rate [Muttray and 
Mohn, 1999]. 
In the following two methods for the amplification of RNA are presented: 
 
2.4.1 One step RT-PCR 
RNA can be amplified by reverse transcription of the RNA into cDNA followed by a PCR 
reaction. This approach, however, has several disadvantages. Due to two separate reac-
tions the risk of a contamination of the sample is increased, as well as time consumption 
and labor. 
In one step RT-PCR (reverse transcription-PCR), both enzymes, the reverse transcriptase 
and the DNA polymerase, are together in one reaction mix, allowing reverse transcrip-
tion and DNA amplification to take place in a one reaction step. First an incubation at 
approximately 37-42°C is carried out for generation of cDNA from the RNA template. 
This step is followed by normal PCR temperature cycles, starting with an incubation step 
at 95°C. Because reverse transcriptase is inactivated at high temperatures and the appli-
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cation of a hot-start DNA polymerase, reverse transcription and DNA amplification reac-
tions do not occur simultaneously but sequentially in a single tube. 
One step RT-PCR kits are distributed by many vendors including Qiagen (OneStep RT-
PCR Kit), Invitrogen (SuperScript™ III One-Step RT-PCR System), Clontech (TITANIUM™ 
One-Step RT-PCR Kit) and Applied Biosystems (TaqMan® Gold RT-PCR Kit). 
 
2.4.2 Nucleic acid sequence-based amplification (NASBA) 
In order to realize reverse transcription of RNA to cDNA and simultaneous amplification 
of cDNA a method called NASBA (nucleic acid sequence-based amplification) was intro-
duced. 
NASBA is an isothermal RNA amplification method utilizing the concurrent activity of 
three enzymes: avian myeloblastosis virus reverse transcriptase (AMV-RT), RNase H, and 
T7 RNA polymerase [Churruca et al., 2007; Morre et al., 1996]. The method was first 
described by Kievits et al. in 1991 and has since then been applied for the detection of 
many pathogens, including human immunodeficiency virus type 1 (HIV-1) RNA [Bruisten 
et al., 1993; van Gemen et al., 1994], Campylobacter jejuni and C. coli in chicken meat 
[Churruca et al., 2007], Escherichia coli [Keer and Birch, 2003] and Mycoplasma pneu-
monia [Loens et al., 2003]. 
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Besides the three already mentioned enzymes, the NASBA reaction also needs oligonuc-
leotide primers, one containing a recognition sequence for T7 RNA polymerase, dNTPs 
and NTPs. Figure 9 shows an overview of the NASBA reaction. It starts with first primer 
annealing (which contains the T7 recognition sequence on the 5’end) to the RNA. The 
reverse transcriptase then synthesizes a complementary strand of cDNA. RNase H di-
gests the RNA from the RNA/cDNA hybrid, allowing the second primer to align to the 
cDNA. The reverse transcriptase then synthesizes the second strand of cDNA. This 
double stranded DNA product is a copy of the original RNA and carries the recognition 
sequence for T7 polymerase. This represents the starting point of the amplification cycle 
in which T7 polymerase in vitro transcribes RNA from the template DNA. These newly 
produced RNAs then serve as template for repeated cycles of amplification. The whole 
reaction is performed at a single temperature and achieves an approximately 106 to 109-
Figure 9: Overview over the nucleic acid sequence-based amplification (NASBA). It ampli-
ficates RNA applying three enzymes: RT (reverse transcriptase), T7 RNA pol (T7 RNA po-
lymerase) and RNase H. RNA is plotted as dotted lines (with color blue and pink for 
RNA(+) and RNA(-), respectively), while cDNA is drawn in continuous lines (color green). 
Primers are short lines (with colors purple and dark green for first and second primers, 
respectively). For detailed information about the NASBA reaction see text. Graphic pre-
sented by Alain Houde at Nucleic Acid based Technologies, Baltimore 2007 
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fold amplification of the target, with the main reaction product being ssRNA [Gracias 
and Mc Killip, 2007; Cook, 2003]. 
 
2.5 Objectives for this work 
This work is based on the “sepsis chip” developed at the ARC (Austria Research Centers) 
by Herbert Wiesinger-Mayr (see Microarray section in the introduction for further in-
formation) and includes the integration of an internal control (spike-in) to the protocol. 
An internal control is a DNA sequence that is not present in the targeted sample, but is 
then spiked into the sample (just before cell lysis) and passes through most working 
steps of the protocol, including DNA extraction from whole blood, DNA amplification 
and hybridization. Therefore the internal control sequences serve as a control for the 
correct functioning of each single step within the whole protocol, including DNA extrac-
tion, PCR and labeling reactions as well as hybridization. 
During this work different plant sequences (from the potato) and 16S rRNA gene se-
quences of methanotrophic bacteria were analyzed for utilization as internal control. 
Sequences of those species were easy to obtain in the laboratory and are naturally not 
present in human blood. In order to use these sequences as internal control, they were 
amplified and the optimal spike-in concentration was determined. In order to detect the 
internal control new probes were designed and incorporated into the microarray chips. 
In combination with internal control the microarray data allow a semiquantitative analy-
sis of samples. An objective of this work was the establishment of a quantification ap-
proach for bacteria applying the sepsis chip. However, quantification applying microar-
ray technology is not exact, since signal intensities underlie considerable fluctuations 
between assays. Therefore, internal control probes and diverse “housekeeping” genes 
are important to control microarray data and quantification results. In order to validate 
the results of microarray quantification, a real-time PCR was established. 
Another research topic was amplification of RNA, since RNA is a better target to assess 
bacterial viability than DNA. Several amplification methods for RNA were tested, includ-
ing one step RT-PCR and a method called nucleic acid sequence based amplification 
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(NASBA). Necessary quantification was realized by real-time PCR and microarray analysis 
(semi-quantitative). Future perspectives are the establishment of a protocol which al-
lows the parallel detection of DNA and RNA with the advantage that the viability status 
of bacteria could be evaluated directly on the chip. 
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3. Material & Methods 
 
3.1 Sepsis Identification chip 
 
3.1.1 Probe design 
Most species specific probes were already in use and tested in previous chip layouts and 
were published by Wiesinger et al., 2006. All new probes for the “Sepsis Identification” 
chip are listed in table 10 in appendix 1.  
The sequences of the plant DNA were obtained by sequencing and the sequence infor-
mation of the 16S rDNA of methanotrophic bacteria and of the housekeeping genes 
were downloaded from the NCBI database [http://www.ncbi.nlm.nih.gov]. After a data-
base of all sequences was established, probes for the microarray were designed. In or-
der to control probe sequences, the arb-silva database 
SSURef_0207_1_4_tree_silva_opt.arb was downloaded and newly designed probes 
were analyzed using arb software. 
Probes were ordered from Microsynth (Balgach, Switzerland) and diluted to a concen-
tration of 100 µM by adding the amount of water indicated in the Quality Certificate of 
Microsynth. All probes carried 5’ oligo thymidine residues as spacer molecules and were 
5’ amino-modified for covalent linkage to the chip surface. 
 
3.1.2 Spotting 
The spotting mix consisted of spotting buffer (6x SSC, 3 M Betain) plus hybridization 
control probe BSrev of a concentration of 3% of the final probe concentration (that were 
15µl of BSrev in 1 ml of spotting mix). Spotting mixtures were prepared in 396 well 
plates by adding 17 µl spotting buffer and 17 µl of the probe solution (100 µM, Micro-
synth). The plate was closed using a gluing metal-foil, centrifuged at 900 g for 1 min and 
stored at -20°C until spotting. 
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Spotting was performed by using the contact arrayer Omnigrid from GeneMachines 
(Genomic Solutions, Ann Arbor, USA) on CSS-100 Silylated glass slides (Cel Associates, 
Pearland, USA). The new chips were tested by hybridizing E. coli and S. aureus DNA. 
 
3.2 Preparation of internal control sequences 
 
3.2.1 Methanotrophic 16S rDNA gene 
The DNA samples of four methanotrophic species were obtained by Levente Bodrossy. 
Details of the methanotrophic species are listed below (see table 2). 
Species name Abbreviation Date of recovery 
Methylocaldum szegediense msz 23.01.1996 
Methylococus capsulatus BL5 mca 17.03.1994 
Methylococus capsulatus BL13 mca 16.03.1994 
Methylosinus trichosporium mtr 14.02.2001 
Methylomicrobium agile mag 14.07.2003 
 
The 16S rRNA genes of the obtained sequences were amplified by PCR (details see PCR 
reaction with MolTaq 16S Kit, Molzym). 
 
3.2.2 Plant DNA 
The genomic potato DNA and the specific primers to amplify sequences of ~1,300 bp, 
were obtained from Frederieke Trognitz. Sequence details are listed in table 3. 
Name of potato DNA 
fragment 
Primers 
15010 15010F, 15010R 
25760 25760F, 25760R 
38025 38025R, 38025R 
 
 
Table 3: Names and primers of potato DNA. F and R in 
primer names represent forward and reverse primers, 
respectively. 
Table 2: Methanotrophic species, used abbreviations and the date of recovery are 
listed. 
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Because the potato is tetraploid, there are four homologous sets of chromosomes with 
different alleles of genes. Thus PCR amplification of the genomic potato DNA with one 
specific primer pair yields up to four slightly different products. However, for the use as 
internal control a product with 100% sequence identity was needed. This was realized 
by cloning PCR products of desired sequences into E.coli hosts followed by the isolation 
of the DNA insert of one particular clone. The detailed protocol is described below. 
3.2.2.1 Cloning protocol 
The cloning of the potato DNA sequences was carried out, using the StrataClone™ PCR 
Cloning Kit (Stratagene, La Jolla, USA) according to the manufacturer’s instructions.  
3.2.2.2 Preparation of the sequences 
The potato genomic DNA was amplified by PCR using the target specific primers (see 
table 3). The PCR was carried out as described in chapter 3.6.3. Aliquots of the PCR 
products were analyzed on an agarose gel to verify amplification of the desired frag-
ment. 
3.2.2.3 Ligation of the insert 
3 µl StrataClone™ Cloning Buffer and 1 µl of StrataClone™ Vector Mix were added to 2 µl 
of the PCR product. The components were mixed by repeated pipetting and then incu-
bated at room temperature for 5 min. Afterwards the reaction was placed on ice. 
3.2.2.4 Transformation of the Competent Cells 
StrataClone SoloPack competent cells were thawed on ice. 1 µl of the cloning reaction 
mixture was added to the competent cells. The transformation mixture was incubated 
on ice for 20 min followed by a heat-shock at 42°C for 45 sec. The cells were immediate-
ly placed on ice for 2 min. 250 µl of SOC medium was added to the transformation reac-
tion and cells were allowed to recover for 1 h at 37°C with agitation. 50 µl and 100 µl of 
the transformation mixture were plated on separate LB-ampicillin-X-gal plates. Plates 
were incubated at 37°C for 24 h followed by storage at 4°C. White clones were success-
fully transformed with potato DNA sequences. 
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3.2.2.5 LB-ampicillin-X-gal plates 
500 ml of plating agar contained 5 g of trypton (Fluka Biochemika, Buchs, Switzerland), 
2.5 g of yeast extract (Fluka Biochemika), 5 g of NaCl (Merck, Whitehouse Station, USA), 
7.5 g of Agar (Fluka Biochemika) and 300 µl of ampicillin (conc.: 100mg/ml). Plates were 
finally mixed with 40 µl of 2% X-gal and spread into Petri dishes. 
3.2.2.6 PCR amplification of vector inserts 
PCR amplification of the inserts was performed using primers M13 forward (GTAAAAC-
GACGGCCAG) and reverse (CAGGAAACAGCTATGAC) (primer sequences against vector 
sites flanking the insert) in a concentration of 0.25 µM, respectively. 20 µl of the PCR 
mixture contained 2 µl 10x buffer (Invitrogen, Carlsbad, USA), 0.8 µl of MgCl2 (50 mM, 
Invitrogen), 2 µl dNTP mix (2.5 mM of dATP, dCTP, dTTP and dGTP each, Roche, Mann-
heim, Germany) and 0.2 µl Taq-Polymerase (5 U/µl, Invitrogen). White clones were 
picked with an inoculating loop. The burden of bacteria was streaked on LB-ampicillin-X-
gal plates. The remaining cells on the inoculating loop were dipped into the PCR tubes 
containing 20 µl of PCR mix for resuspension of cells. PCR cycling included an initial de-
naturation step at 95°C for 10 min, followed by 35 cycles at 95°C for 1 min, 55°C for 1 
min and 72°C for 1 min using a Biometra 7300 Thermocycler (Goettingen, Germany). 
Temperature cycles were terminated at 72°C for 10 min. PCR products were stored at 
-20°C upon sending to sequencing. 
In order to be able to amplify the plant sequences along with the 16S rRNA gene of pa-
thogens, it was necessary to ligate the standard pathogen primer sequence to the plant 
amplicons. This was realized by PCR amplifying the plant sequences with specific adap-
ter primers. These adapter primers consisted of sequences specific to the plant DNA 
plus the sequences of the standard 16S rDNA primers (sequences see table 12). Amplifi-
cation with adapter primers was carried out applying the MolTaq 16S PCR Kit (Molzym, 
Bremen, Germany) as described in chapter 3.6.3. 
PCR products were all diluted accordingly (1/10,000) before adding them to another 
PCR. This dilution is very important, as PCR reacts very sensitive to vast amounts of DNA 
and satisfactory amplification was only achieved with decent amounts of inserted DNA.  
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3.3 Quantification of internal control DNA 
Internal control DNA amplified by PCR was purified using the MSB Spin PCRapace Kit 
(Invitek, Berlin, Germany). The protocol is described here briefly: 250 µl of Binding Buf-
fer (Invitek) were added to the PCR sample, mixed well and transferred onto a provided 
Spin Filter column. Columns were centrifuged at 12,000 rpm for 3 min. To elute the puri-
fied PCR products, the Spin Filter column was transferred to a 1.5 ml receiver tube and 
50 µl of Elution Buffer (Invitek) were added to the surface of the column membrane. An 
incubation period for 1 min at room temperature was followed by a centrifugation of 
the columns at 10,000 rpm for 1 min. 
Then the purified methanotrophic and plant DNA was quantified via NanoDrop® mea-
surements giving the DNA concentration in ng/µl. The corresponding DNA sequences 
were copied into BioEdit v.7.0.9 and the program calculated the length, nucleotide 
composition and also the molecular weight in Dalton of one copy of dsDNA. The conver-
sion factor of Dalton to kilogram is 1.660538782×10−27. Therefore, the molecular weight 
in Dalton multiplied by the conversion factor gives the weight in kilogram per DNA copy, 
which can be easily converted to nanogram per DNA copy. The result of the NanoDrop® 
measurement in ng/µl is then divided by the nanogram per DNA copy, giving the result 
of copy number per µl. 
 
3.4 DNA isolation from bacterial culture 
 
3.4.1 Bacterial culture 
All reference strains tested in this study were obtained from the American type culture 
collection (ATCC) or the “Deutsche Sammlung für Mikroorganismen und Zellkultur” 
(DSMZ). For long term storage all bacterial strains were kept as 30% glycerol stocks at 
-80°C. 1 ml of an overnight culture of the bacterial strain (in Caso-Bouillon, incubated at 
37°C, 160 rpm) was transferred into an eppendorf tube. The cells were centrifuged at 
5,000 rpm for 5 min, supernatants were discarded and pellets were resuspended in 1 ml 
1x PBS and again centrifuged at 5,000 rpm for 5 min. This washing step was repeated 
once. Finally the pellet was taken up in 1 ml 1x PBS. The suspension was diluted 1/10 
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and the optical density at 625 nm was determined. The cell concentration was adjusted 
to 108 cells per ml by comparing to Mc Farland standard # 0.5. The calculated volume 
was transferred into a new eppendorf tube and TE buffer (for lysis applying the Epicen-
tre kit; 10 mM Tris-HCl [pH 8.0], 1 mM EDTA, Epicentre) or ddH2O (for other lysis me-
thods) was added to a final volume of 100 µl (final concentration = 108 cells/100 µl). This 
suspension was the starting material for different lysis experiments. 
 
3.4.2 Lysis of the bacterial cells 
Several methods of bacterial cell lysis were tested and compared during this work. 
3.4.2.1 Cell lysis applying a commercial kit 
The Master Pure Gram Positive DNA Purification Kit (Epicentre, Madison, USA) was used 
for cell lysis. The protocol was adapted to our requirements. 1 µl of Ready Lyse Lysozym 
was added to the cell suspension followed by incubation for 30 min at 37°C. 1 µl of pro-
teinase K (50 µg/µl) was diluted into 100 µl of Gram Positive Lysis Solution and added to 
the cell suspension. The cells were then incubated at 65°C for 15 min followed by a 
heating step at 95°C for 15 min. Before proceeding with DNA and RNA extraction, 500 µl 
of buffer RLT Plus + 1 % β-mercaptoethanol (RNeasy Plus lysis buffer, Qiagen) were add-
ed to the sample. 
3.4.2.2 Boiling protocol 
The cell suspension was heated to 95°C for 15 min briefly vortexed and centrifuged 
(15,000 g, 10 min). The supernatant (contained the bacterial DNA) was transferred to a 
new tube. In order to separate DNA and RNA with the Qiagen kit (see chapter 3.4.3. 
“DNA and RNA purification”) 600 µl of buffer RLT Plus were added. 
3.4.2.3 Bead beating 
600 µl of buffer RLT Plus + 1 % β-mercaptoethanol (Qiagen, Venlo, Netherlands) were 
added to the cell suspension before putting the mixture onto 0.1 mm silica spheres (MP 
Biomedicals, Solon, USA). Then, the sample was blended three times in a bead beater 
(Fast Prep FP120, MP Biomedicals) for 30 sec at maximal setting. The suspension was 
then centrifuged at 15,000 g for 15 min. The supernatant was proceeded for DNA and 
RNA extraction applying the Qiagen kit. 
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3.4.2.4 Lysis applying the RLTPlus buffer (Qiagen) 
RLT Plus buffer + 1 % β-mercaptoethanol (Qiagen) was added to the cells at a certain 
step of each lysis method. However, for this protocol the cells were solely lysed by addi-
tion of 600 µl buffer RLT Plus. 
The extracted DNA was purified using the AllPrep DNA/RNA Mini Kit (Qiagen), in order 
to obtain DNA and RNA ready for molecular methods. 
 
3.4.3 DNA and RNA purification 
DNA and RNA purification was carried out applying the AllPrep DNA/RNA Mini Kit (Qia-
gen). After addition of buffer RLT Plus (step 3 in the AllPrep DNA/RNA Mini handbook, 
11/2005 protocol) all steps were realized according to the protocol. Homogenization of 
the cells, as described in step 3 of the protocol, was not necessary since we were not 
working on cell tissue but bacterial cell culture. 
The lysed cells were transferred onto an AllPrep DNA spin column and centrifuged for 
30 sec at 10,000 rpm. RNA flows through while the DNA binds to the column and is kept 
for later processing. 
3.4.3.1 Total RNA Purification 
The flow-through, which contains the RNA, was mixed with one volume of 70 % ethanol 
by pipetting. Up to 700 µl of the sample were transferred to an AllPrep RNA spin column 
and centrifuged at 10,000 rpm for 15 sec. The flow-through was discarded.1 
Then 700 µl of buffer RW1 were added to the spin column and again centrifuged at 
10,000 rpm for 15 sec. The flow-through was discarded. The same procedure was done 
with 500 µl of buffer RPE to wash the spin column membrane. This washing step was 
repeated once by addition of 500 µl of buffer RPE and centrifuged at 10,000 rpm for 
2 min. After the flow-through was discarded the column was again centrifuged at full 
speed for 1 min to remove any traces of the washing buffer. The column was then 
placed in a DNA-free collection tube and 50 µl of RNase-free water were added. A last 
                                                      
1 starting point for optional On-Column DNase Digestion see chapter 3.4.3.3 
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centrifugation at 10,000 rpm for 1 min was carried out to elute the RNA. All RNA was 
stored at -20°C until use. 
3.4.3.2 Genomic DNA purification 
500 µl of buffer AW1 were added to the AllPrep DNA spin column and centrifuged at 
10,000 rpm for 15 sec. After the flow-through was discarded, 500 µl of buffer AW2 were 
added to the column and centrifuged at full speed for 2 min, to wash the membrane. 
The column was then placed in a collection tube and 100 µl of elution buffer EB were 
added to the membrane. After an incubation time of 1 min the DNA was eluted by cen-
trifugation at 10,000 rpm for 1 min and stored at -20°C. 
3.4.3.3 Optional On-Column DNase Digestion Using the RNase-Free DNase Set 
First the DNase I stock solution was prepared by injecting 550 µl RNase-free water into 
the vial containing DNase I, using a needle and syringe. DNase I stock solution was then 
stored in single-use aliquots at -20°C. For DNase digestion the RNA purification protocol 
was followed until the washing steps with buffer RW1. The step in the Total RNA Purifi-
cation protocol, at which optional DNase Digestion starts, is indicated by a footnote in 
the text. 350 µl of buffer RW1 were added to the AllPrep RNA spin column and centri-
fuged for 15 sec at 10,000 rpm to wash the membrane. 10 µl of DNase I stock solution 
were gently mixed with 70 µl of Buffer RDD. The resulting DNase I incubation mix was 
added to the column membrane and incubated at room temperature for 15 min. After 
incubation 350 µl of buffer RW1 were added to the membrane and centrifuged for 
15 sec at 10,000 rpm. After discarding the flow-through the Total RNA Purification pro-
tocol was continued starting with the first addition of buffer RPE. 
 
3.5 Pathogen DNA Isolation from whole blood 
Various methods for the isolation of bacterial DNA from whole blood were tested by 
Herbert Wiesinger-Mayr. Good results combined with ease of use were obtained by the 
MolYsis Kit from Molzym. Therefore, this protocol was used to isolate pathogenic DNA 
from whole blood and also for experiments with internal control DNA addition just be-
fore cell lysis. 
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3.5.1 Preparation of bacterial culture 
1 ml overnight (o/n) culture of a bacterial strain (in 6 ml Caso-Bouillon, incubated at 
37°C, 160 rpm) was transferred into an eppendorf tube. The cells were centrifuged at 
5,000 rpm for 5 min, supernatants were discarded and pellets were resuspended in 1 ml 
1x PBS. This washing step was repeated once. Suspensions with three different cell con-
centrations were prepared. A bacterial suspension with a concentration of 108 cells per 
ml was prepared applying the McFarland standard #0.5 (see chapter 3.4.1 “bacterial 
culture”). The 106 and 105 cells/ml suspensions were made by diluting the 108 cells/ml 
cell suspension accordingly. 
 
3.5.2 Spiking of whole blood 
70 µl bacterial cell suspension were added to 7 ml of whole blood. Therefore, the final 
pathogen concentration in whole blood was 103 to 106 cells per ml. 1 ml of the spiked 
blood was then aliquoted into new eppendorf tubes. The internal control DNA was add-
ed later in the protocol, just before bacterial cell lysis. 
 
3.5.3 Bacterial DNA isolation applying MolYsis Kit 
DNA isolation was performed according to manufacturer’s instructions (Molzym).  
3.5.3.1 Human cell lysis 
250 µl of buffer CM were added to 1 ml of whole blood and vortexed at full speed for 
approximately 20 sec. Then 250 µl of buffer DB1 and 10 µl of MolDNAseB were added 
and vortexing for appr. 20 sec was repeated, followed by an incubation step at room 
temperature (RT) for 15 min. The bacterial cells were harvested by centrifugation at 
13,000 rpm for 10 min and decantation of the supernatant. 
3.5.3.2 Bacterial cell lysis 
Cells were washed by addition of 1 ml of buffer RS and vortexed for 10 sec. Cells were 
again harvested by centrifugation at 13,000 rpm for 5 min and decantation of the su-
pernatant. The bacterial pellet was resuspended in 80 µl of buffer RL by pipetting and 
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vortexing for 10 sec. After addition of 20 µl of BugLysis solution the cells were again vor-
texed for 10 sec, followed by addition of internal control DNA. An incubation step at 
37°C and 1,000 rpm for 30 min was carried out prior to transferring 150 µl of buffer RP 
and 20 µl of Proteinase K to the cells and vortexing for 10 sec. Subsequent to an incuba-
tion step at 56°C and 1,000 rpm for 10 min, 250 µl of buffer CS were added and vortexed 
for 10 sec. 
3.5.3.3 DNA purification 
For DNA purification 250 µl of binding buffer were added to the cell lysate and vortexed 
for 10 sec. The suspension was then transferred to a spin column and centrifuged at 
13,000 rpm for 30 sec. The flow-through was discarded and the spin column was re-
placed to the collection tube. 400 µl of buffer WB were added to the column and the 
column was centrifuged at 13,000 rpm for 30 sec. The flow-through was discarded and 
the column was washed with 400 µl of DNA-free 70% ethanol. Subsequent to this wash-
ing step the column was centrifuged at 13,000 rpm for 3 min. Then the column was 
transferred to a 1.5 ml elution tube and 100 µl of DNA-free deionized water (preheated 
to 70°C) were added and the column was incubated for 1 min. In order to elute the DNA 
the column was centrifuged at 13,000 rpm for 1 min. Eluted DNA was stored at -20°C 
until further usage. 
 
3.6 Amplification of bacterial 16S rDNA 
Several PCR master mixes were tested in order to increase efficiency and minimize risk 
of contamination. 
 
3.6.1 PCR applying Taq DNA Polymerase 
Recombinant Taq DNA Polymerase (Invitrogen) was used as standard protocol. PCR am-
plification of 16S rRNA gene was realized applying the forward primer 45 and the re-
verse primer 1391 (0.6 µM) (Microsynth). Primer sequences are listed in Appendix 1. A 
25 µl PCR mixture contained 2.5 µl 10x PCR buffer (Invitrogen), 1 µl MgCl2 (50 mM, Invi-
trogen), 2 µl dNTP mix (2.5 mM of dATP, dCTP, dTTP and dGTP each, Roche, Mannheim, 
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Germany), 0.25 µl Taq-Polymerase (5 U/µl, Invitrogen) and 1 µl of bacterial DNA extrac-
tion. 
 
3.6.2 PCR applying the ImmoMix Red Kit 
The ImmoMix Red kit (Bioline, London, UK) is a ready-to use PCR mixture. 25 µl of PCR 
mix contained 12.5 µl of 2x PCR buffer (Bioline), 0.5 µl of primers forward and reverse, 
each (15 µM) (Microsynth) and 1 µl of target DNA. The Immomix Red buffer contains a 
red dye, making the addition of loading buffer for gel electrophoresis, obsolete.  
 
3.6.3 PCR applying the Molzym 16S basic mix 
Molzym 16S basic mix is a guaranteed DNA-free PCR mix (Molzym, Bremen, Germany). 
25 µl of PCR mix contained 0.5 µl of primers forward and reverse, each (15 µM) (Micro-
synth), 10 µl of 2.5x PCR mix, 0.8 µl of MolTaq polymerase and 1 µl of target DNA. 
 
3.6.4 Cycling conditions 
PCR cycling conditions were the same for all PCR mixes and included an initial denatura-
tion step at 95°C for 5 min, followed by 40 cycles of 95°C for 1 min, 55°C for 1 min and 
72°C for 1 min using a Biometra 7300 Thermocycler (Goettingen, Germany). Tempera-
ture cycles were terminated at 72°C for 10 min to complete partial amplicons, followed 
by storage at 4°C until further usage. 
Successful amplification was confirmed by transferring 9 µl of the PCR products plus 1 µl 
of 10x loading buffer) on a 1.5 % agarose gel (SeaKem; Biozym, Oldendorf, Germany) in 
TBE buffer (0.1 M Tris, 90 mM boric acid, 1 mM EDTA) (Invitrogen) supplemented with 
ethidium bromide. The run was carried out at 170 mV for 45 min. 
 
3.7 Primer Extension 
The primer extension method was used for labeling of 16S rDNA PCR products. 6 µl of 
the PCR product was added to the primer extension mix containing 1.5 µl of forward 
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primer 45 (15 µM), 2.5 µl of 10x ThermoPol buffer (New England BioLabs Inc., Ipswich, 
Massachusetts), 0.5 µl of dNTP mix (10 mM of dGTP, dATP and dTTP, 5 mM of dCTP, 
Roche), 0.5 µl of Atto 532 labeled dCTP (5 mM, Mo Bi Tec, Göttingen, Germany), 0.25 µl 
of MgSO4 (100 mM, New England BioLabs Inc.), and 0.8 µl of Vent (exo-)polymerase 
(2 U/µl, New England BioLabs Inc.) for a 25 µl reaction volume. Cycling program started 
with a denaturation step at 95°C for 3 min, followed by 25 cycles of 95°C for 20 seconds, 
60°C for 20 sec and 72°C for 20 sec. Primer extension was completed at 72°C for 3 min 
followed by storage at 4°C until further usage. 
 
3.8 Hybridization with glass cover slip 
Before hybridization, slide surfaces were blocked in urea buffer (3 M urea, 0.1% SDS) for 
30 minutes, shortly washed in WashII (0.1 x SSC, 0.2 % SDS) and dried by centrifugation 
(900 rpm for 2 min in a Multifuge 3 S-R from Heraeus). A hybridization mix containing 
6.25 µl of 20x SSC, 0.3 µl of 10% SCS and 0.5 µl of a hybridization control (10 nM, BSrev: 
5’end Cy5-labeled oligonucleotide sequence: AAG CTC ACT GGC CGT CGT TTT AAA) was 
added to 25 µl of the labeled primer extension product. The mixture was heated to 95°C 
for 3 min for denaturation of DNA strands. To start the hybridization reaction 24 µl of 
this mixture were transferred on a cover slip (22 x 22 mm) and subsequently applied to 
the microarray surface. Hybridization was realized at 65°C in a vapor saturated pre-
heated chamber for 1 hour. 
 
3.9 Hybridization with Agilent Slides 
The applied protocol was similar to the hybridization using glass cover slips except for 
processing Agilent slides an increased hybridization volume of 100µl was needed. There-
fore the Primer Extension reaction was carried out in a volume of 50µl. The primer ex-
tension products were then diluted in dH2O to a volume of 75µl. The volumes of the 
hybridization mix were changed to 21.4 µl of 20x SSC, 1.1 µl of 10% SDS and 1.7 µl of 
hybridization control. After denaturation (95°C for 3 min), 100 µl of the mixture were 
transferred onto the Agilent Slides (Agilent Technologies, Santa Clara, USA). Then the 
microarray was applied (see figure 10a). The Agilent hybridization chamber (see figure 
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10b), was assembled following the manufacturer’s instructions. Hybridization was 
realized at 65°C for 1 hour at 10 rpm. 
 
3.10 Washing procedure after hybridization 
After hybridization slides were washed first in 2x SSC, 0.1 % SDS for 5 min, then in 
0.2x SSC for 2 min and finally in 0.1x SSC solutions for 1 min. Afterwards slides were 
again dried by centrifugation (900 rpm, 2 min). 
 
3.11 Signal detection and analysis 
Slides were scanned at a resolution of 10 µm with an Axon Genepix 4000A microarray 
scanner (Axon, Union City, California) at two different sensitivity levels of the photomul-
tiplier for each slide. Those were 500 pmt (photo multiplier) and 600 pmt each for red 
and green channels in two-color analysis, respectively. Obtained images were analyzed 
using the Genepix software. A grid specifying the name of each probe and the position 
on the microarray was created by Omnigrid software (Genomic Solutions, Ann Arbor, 
USA). This grid was imported into Genepix software and placed across the microarray 
image either manually or automatically by the software. The software then performed 
background correction by applying the following formula:  
 
Figure 11 illustrates signal intensity values of probes and background signal intensities. 
Figure 10: Agilent hybridization technology; A: first steps in assembly of Agilent hybridiza-
tion chamber; B: Agilent hybridization chamber, picture by Agilent Technologies 
A B 
Agilent slide 
with four 
hybridization 
“chambers” 
Spotted 
areas on 
microarray 
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Each probe was spotted on the array fourfold (quadricates). The arithmetic mean of 
these four spots was also calculated by the GenePix software. All results were exported 
as gpr (GenePix results) files. Graphs were generated in Excel software by drawing the 
background corrected arithmetic mean signal values of quadricate probes (y-axis) 
against the probe name (x-axis). 
 
3.12 Real-Time PCR 
Two different kits for real-time PCR were applied: the SYBR® Green PCR Master Mix and 
the TaqMan® Universal PCR Master Mix (each from Applied Biosystems, Foster City, 
USA). 
 
3.12.1 SYBR® Green PCR Master Mix 
PCR amplification of 16S rRNA gene was realized using the primer pair 521F and 673R 
(900 nM, Microsynth). The 20 µl PCR mixtures contained 10 µl 2x PCR buffer (Applied 
Biosystems), and 2 µl template DNA. 
PCR cycling included an initial denaturation step at 95°C for 10 min, followed by 40 
cycles of 95°C for 15 sec and 60°C for 1 min using the GeneAmp® 5700 Sequence Detec-
tion System from Applied Biosystems. After realization of the temperature cycles a melt-
ing curve analysis was carried out, by heating the sample from 60°C to 95°C. 
 
3.12.2 TaqMan® Universal PCR Master Mix 
Probe signal intensities 
Background signal intensities 
Figure 11: Illustration of probe and background signal intensities. A grid specifying the 
exact position and name of each probe was applied either manually or automatically by 
the Genepix software. The mean of absolute signal intensities within the defined area 
of the probe was calculated, as well as the mean of signal intensities in the area of 
three times the diameter of the spot around each probe (background signal).  
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Primers 331F and 797R were added to real-time PCR for a final concentration of 900 nM. 
The 20 µl PCR mix further contained 10 µl of 2x TaqMan PCR Master Mix (Applied Bio-
systems), 2 µl of the TaqMan probe (2.5 µM, Microsynth) and 1 µl of the template DNA. 
Cycling conditions were equal to SYBR® Green PCR conditions, except the opportunity to 
carry out melting curve analysis. 
 
3.12.3 Data analysis 
Data analysis was the same for SYBR® Green real-time PCR and for TaqMan® Universal 
PCR. 
The raw data was the fluorescence intensity measured after each thermal cycle. The raw 
data of real-time PCR analysis was plotted on a logarithmic scale with fluorescence 
drawn on the y-axis and cycle number drawn on the x-axis. 
The threshold cycle was defined as cycle number, at which specific signals of the sam-
ples clearly increased and were distinguishable from background signals. At that point 
amplification has reached the logarithmic phase, making the increase in fluorescence 
linear on a logarithmic scale. This cycle number is calculated by the GeneAmp 5700 SDS 
software. 
For DNA quantification a standard curve was generated. It is a dilution series of DNA 
with known concentration. In a 1/2 dilution series threshold cycles between single dilu-
tion steps should differ by one cycle. In order to determine the efficiency of the PCR as 
well as suitability for quantification, a line chart was produced, with the dilutions steps 
on the x-axis and the threshold cycles on the y-axis. A trendline was plotted, with the 
equation and the R-squared value displayed in the chart. The equation is important for 
quantification and will be discussed in detail later. The R-squared value represents the 
efficiency of the PCR reaction and should ideally be above 0.9. An R-squared value of 1 is 
achieved when the reaction is 100% efficient, meaning that the amount of DNA doubles 
in every cycle.  
The equation in the line chart with two variables x and y is as follows:  
The two constants m and b define the slope of the graph and the crossing point of the 
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graph with the y-axis, respectively. By inserting the threshold cycle of the unknown 
sample in the equation as y value the variable x can be calculated. The variable x 
represents the dilution step of the standard curve which equals the unknown sample in 
respect to the DNA concentration. If the concentration of the unknown sample is exactly 
the same as one dilution step of the standard curve, then x is an integer. Normally the 
value x is a rational number and therefore positioned somewhere between two steps of 
the dilutions series. To determine the concentration of the unknown sample a second 
equation is necessary. For a 2 fold dilution series with the highest concentration being 
100,000 copies per reaction this equation is:  
 
By inserting the already calculated variable x as x in this second equation and then calcu-
lating the y value, the exact concentration of the unknown sample is determined. 
3.12.3.1 Dissociation curve analysis in SYBR® Green real-time PCR assays 
In order to proof specific product amplification a dissociation curve analysis was carried 
out. Unspecific amplification as well as primer dimers were visualized as further peaks in 
the dissociation curve. Dissociation curve analysis takes place after thermocycling and is 
realized by slowly increasing the sample temperature from 60°C to 95°C. When the 
temperature reaches the melting point of a specific PCR product, the two strands of 
dsDNA separate, leading to a decrease of fluorescence.  
 
3.13 RNA based techniques 
RNA from bacterial culture was obtained as described earlier (see M&M Testing of dif-
ferent lysis methods for bacteria) and dilution series of these bacterial RNA suspensions 
were prepared (dilutions 1x, 1/5, 
1/25). 
 
3.13.1 Omniscript Reverse Transcription Kit (Qiagen) 
Reverse primer 1391 (1.1 µM, Microsynth, Balgach, Switzerland) was used for reverse 
transcription of RNA into cDNA. No forward primer was needed for this reaction. 2 µl 
10x buffer RT, 2 µl dNTP mix (5 mM each dNTP, Roche), 1 µl RNase Inhibitor (10 U/µl, 
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Qiagen), 1 µl Reverse Transcriptase (4 U/µl) and 10 µl of diluted RNA were mixed and 
diluted with H2O to a final volume of 20 µl as recommended in the Omniscript Reverse 
Transcription Handbook 05/2004. The reverse transcription reaction was carried out at 
37°C for 60 min. 
 
3.13.2 Superscript Reverse Transcription Kit (Invitrogen) 
0.5 µl of forward primer 45 (15 µM, Microsynth), 0.5 µl of reverse primer 1391 (15 µM, 
Microsynth) and 1 µl of dNTP mix (10mM, Roche) were added to 10 µl of diluted RNA 
and then heated to 65°C for 5 min, followed by an incubation on ice for at least 1 min. 
Then 4 µl of 5x first-strand buffer (Invitrogen), 1 µl of 0.1 M DTT (Qiagen), 1 µl of RNase 
Inhibitor (10 U/µl, Qiagen), 1 µl of H2O and 1 µl of Superscript III Reverse Transcriptase 
(200 U/µl, Invitrogen) were added to a final volume of 20 µl. Reaction conditions were 
52°C for 60 min followed by 70°C for 15 min. 
 
3.13.3 Avian Myeloblastosis Virus (AMV) Reverse Transcriptase (Invitrogen) 
0.5 µl of forward primer 45 (15 µM, Microsynth), 0.5 µl of reverse primer 1391 (15 µM, 
Microsynth) and 2 µl of dNTP mix (10 mM, Roche) were added to 10 µl of template RNA 
and then heated to 65°C for 5 min, followed by an incubation on ice for 1 min. Then 4 µl 
of 5x cDNA synthesis buffer (Invitrogen), 1 µl of 0.1 M DTT (Qiagen), 1 µl of RNase Inhibi-
tor (10 U/µl, Qiagen) and 1 µl of Cloned AMV Reverse Transcriptase (15 U/µl, Invitrogen) 
were added to a final volume of 20 µl. Reaction conditions were 45°C for 60 min fol-
lowed by 85°C for 15 min. 
2 µl of cDNA were amplified in a following PCR. PCR and gel analysis of products were 
performed as described above. 
 
3.13.4 One-Step RT-PCR Kit (Qiagen) 
Primers 45F and 1391R (sequences see table 11 in Appendix 1) were used at a final con-
centration of 0.6 µM. 25 µl reaction mixture contained 5 µl 5x OneStep RT-PCR buffer, 
10 µl H2O (RNase free), 1 µl dNTP mix (10 mM of each dNTP, Qiagen), 1 µl of RNase Inhi-
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bitor (10 U/µl, Qiagen), 1 µl of OneStep RT-PCR Enzyme Mix (Qiagen) and 5 µl of tem-
plate RNA. For reverse transcription reaction the samples were incubated at 50°C for 
30 min. An initial PCR activation step at 95°C for 15 min was followed by 40 temperature 
cycles of 95°C for 1 min, 55°C for 1 min and 72°C for 1 min using a Biometra 7300 Ther-
mocycler (Goettingen, Germany). Temperature cycles were terminated at 72°C for 
10 min, followed by storage at 4°C until further usage. 
 
3.13.5 Home-made NASBA 
Reverse primers (internal name: 317R_T7, 673R_T7 and 1391R_T7) consisted of the T7 
promotor sequence plus a sequence specific for the 16S rRNA. The standard 45 forward 
primer (also used for standard PCR amplifications) was used for NASBA reactions. NAS-
BA reaction was realized as previously described by Song et al., 2000. Reactions were 
carried out in a volume of 25 µl, consisting of 5 µl RNA dilution, 3.8 µl enzyme mix and 
15.4 µl amplification mix (40 mM Tris-HCl pH 8.4, 2 mM each NTP (Roche), 1 mM each 
dNTP (Roche), 10 mM DTT, 12 mM MgCl2, 90 mM KCl, 0.18 µM of each primer and 15% 
DMSO). Enzyme mix containing 40 U T7 polymerase (Roche), 7.5 U AMV-RT (Invitrogen), 
0.2 U RNase H (New England Biolabs Inc.), 10 U RNase Inhibitor (Qiagen) and 400 µg/ml 
BSA (Sigma Aldrich, St. Louis, Missouri) were added to the reaction after denaturing tar-
get RNA at 65°C for 5 min and incubation at 41°C for 5 min. Reactions were incubated 
for 90 min at 41°C. Products were loaded onto 1.5% agarose gels for analysis. 
 
3.13.6 NASBA applying the NucliSENS EasyQ® Basic Kit v2 (Biomérieux) 
All steps were performed according to the NucliSENS EasyQ® Basic Kit v2 Guidance doc-
ument (Biomérieux, Lyon Area, France). Typically the NASBA mix was prepared for eight 
samples, since the lyophilized enzyme and reagent spheres were aliquoted for this sam-
ple number. First the enzyme solution was prepared by adding 45 µl enzyme diluent to 
the lyophilized enzyme sphere. The solution was placed at room temperature for 5 min 
before gently mixing by tapping the tube. The target RNA specific primer mix was pre-
pared by diluting 10 µl of each primer (15 µM) with 10 µl of water (included in the kit). 
The KCl solution (80 mM) was prepared by mixing 16 µl KCl stock solution with 14 µl 
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water. 64 µl reagent sphere diluent, 24 µl KCl solution and 8 µl primer mix were trans-
ferred to a new tube and briefly vortexed. Finally the reagent sphere was added and 
vortexed immediately until a clear solution was obtained. Each PCR tube was supple-
mented with 5 µl of target RNA and 10 µl primer reagent mix. Subsequent to vortexing 
the tubes were placed in the thermocycler. Incubation was carried out at 65°C for 2 min 
followed by 41°C for 2 min. Then 5 µl of the enzyme solution were added to each tube 
and the samples were incubated at 41°C for 90 min, followed by storage of the products 
at 4°C. 
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4. Results & Discussion 
 
4.1 Probe design for the “Sepsis Identification” chip 
A database for arb software package [Ludwig et al., 2004] was established, which was 
the basis for specific probe and primer design. 16S rRNA gene sequences from methano-
trophic bacteria and DNA sequences from housekeeping genes were obtained from the 
ncbi database [http://www.ncbi.nlm.nih.gov] and subsequently loaded into arb data-
base. Amplified plant DNA was sequenced and the results were loaded into the arb da-
tabase. Data analysis was carried out using the probe design function of the arb soft-
ware package and as result the DNA sequences for primers and probes were obtained. 
The sequences are listed in table 10 in Appendix 1. 
The phylogenetic tree based on 16S rDNA analysis shows the relation between the pa-
thogens represented on the “Sepsis Identification” chip. An illustration can be seen in 
figure 12. 
Streptococcus pneumoniae 
Streptococcus pyogenes 
Enterococcus faecium 
Staphylococcus aureus 
Staphylococcus epidermidis 
Enterococcus faecialis 
Methylosinus trichosporium 
Methyomicrobium agile 
Methyolcoccus capsulatus 
Methyolcaldum szegediense 
Pseudomonas aeroginusa 
Acinetobacter johnsonii 
Acinetobacter lwoffii 
Acinetobacter radioresistens 
Acinetobacter baumannii 
Proteus mirabilis 
Proteus vulgaris 
Morganella morganii Citrobacter freundii 
Klebsiella oxytoca 
Enterobacter cloacae 
Klebsiella pneumoniae 
Enterobacter aerogenes 
Serratia marcescens 
Escherichia coli 
Citrobacter koseri 
Candida parapsilosis 
Candida glabrata 
Candida tropicalis 
Candida albicans 
Figure 12: Phylogenetic tree based on 16S rDNA analysis showing the relations between 
pathogenic species represented on the sepsis identification chip. 
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4.1.1 Hybridization control BSrev 
The spotting mix consisted of spotting buffer plus hybridization control probe BSrev at a 
final concentration of 3 % of the total probe concentration. The target for BSrev was 5’ 
labeled with the dye Cy5 (emits red light), therefore it was distinguishable from the am-
plified pathogen sequences which were Atto 532 (emits green light) labeled. As BSrev 
was added to the spotting buffer, all probes contained BSrev and gave weak Cy5 signals 
at 635 nm. The BSrev specific signal intensities between different probes showed big 
differences, although the spiked-in BSrev concentration was the same. Additionally, 
BSrev specific signals were continuously decreasing the longer the spotted slides were 
stored before hybridization (see figure 13). 
 
Four weeks after spotting of the slides probes gb2 ecl and eco2 generated BSrev specific 
signals of 13,800 and 3,400, respectively. Signal intensities for these probes dropped to 
2,000 and 350, when hybridization was performed four months after spotting. There-
fore, those two spots demonstrated the differences in BSrev signal intensities as well as 
their decrease over time very well. The decrease in signals intensities was observed for 
all spots. Probe BSrev (100 % BSrev spotted) showed the highest signal of 52,300 shortly 
after spotting and dropped considerably over the next four months to 10,000. This ef-
fect was also observed with the mean values of BSrev specific signals of all probes, 
where the signals decreased from 3,600 to 400 over the course of 19 weeks. This de-
Figure 13: Signals of spiked-in BSrev of selected probes over 19 weeks. Signal intensi-
ties are plotted on the y-axis while the weeks after spotting are plotted on the x-axis. 
Probe BSrev (100 % BSrev), negative control 3x SSC (buffer control plus 3 % BSrev) and 
probe gb2 ecl (A) showed high BSrev specific signals while probes eco2 and eco3 (B) 
generated relatively low signals. BSrev all shows the mean values of BSrev specific sig-
nals of all probes of a microarray. 
A B 
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crease in signals was only observed for BSrev specific signals and not for pathogen spe-
cific signals. 
As BSrev was added to the pathogen specific probes, each spot would emit signals of 
both wave lengths as BSrev (Cy5 labeled) and the pathogenic DNA (labeled with Atto 
532) bind to the probes in these spots. The effects of pathogen specific signals on BSrev 
signals were determined by the example of E. coli specific probe eco2 and eco3. High 
and low pathogen specific signals were compared to respective BSrev signals (see figure 
14). No correlation could be detected. Fluctuations in BSrev signal intensities do not 
correspond to the signal intensities of pathogen specific probes but are dependent on 
the age of the chips. 
 
4.2 Establishment of internal control 
The internal control was added for proof of each working step of the microarray proto-
col. The signals of the internal control monitor the efficiency of DNA isolation, PCR am-
plification, labeling reactions and hybridization. During each working step the internal 
control sequence must not interfere with the analysis of pathogenic DNA from the sam-
ple. 
 
4.2.1 Preparation of internal control DNA 
Figure 14: E. coli specific and BSrev signals of probes eco2 (A) and eco3 (B) in different 
experiments. Fluorescence signal intensities (SI) were plotted on the y-axis while hy-
bridizations where plotted on the x-axis. Values were sorted by E. coli specific signal 
intensities (green bars) from smallest to largest. Red bars indicate BSrev signal intensi-
ties. In order to plot both (green and red) signals on one axis, the green signals (Atto 
532) were divided by 10. 
A B 
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The following chapters will describe the results of the establishment of an internal con-
trol into a pathogen identification protocol. Further the internal control supports semi-
quantitative analysis based on chip technology. 
4.2.1.1 Potato sequences 
Potato DNA was thankfully received from Frederieke Trognitz. PCR was realized with 
three different primer pairs (15010F and R; 25760F and R; 38025R and R) targeting dif-
ferent fragments, each amplifying sequences of ~1,400 bp. PCR products were loaded 
onto 1.5 % agarose gels, purified and the DNA concentration was measured using Na-
noDrop. 
The potato is a tetraploid plant and therefore has four homologous sets of chromo-
somes. For the usage as internal control, however, it is important that only one com-
pletely homologous sequence is prevalent in one sample. Thus the amplified sequences 
were cloned into E. coli and enriched by cultivation. PCR amplification of the insert of 
one single clone ensured that only one allele was amplified in one sample. 
Cloning was achieved, using the StrataClone™ PCR cloning kit. The LB-plates carrying the 
transformed clones are shown in figure 15. White clones were successfully transformed, 
while blue clones did not carry any plant sequences. 
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Four white clones of each plate were selected and the extracted plasmids were used as 
template for PCR amplification. Figure 16 shows the PCR products of the four isolations 
per DNA sequence. Amplified potato DNA samples were then prepared for sequencing. 
Figure 15: Pictures of transformed E. coli clones plated onto LB-ampicillin-X-gal plates. 
15010 and 38025 correspond to the plant sequences, used for cell transformation. White 
colonies: successfully transformed clones; Blue colonies: did not uptake any plasmid, thus 
they did not carry any plant sequences 
15010 38025 
Figure 16: 1.5% agarose gel showing PCR products of each clone insert. Four 
clones of each target DNA sequence were picked and amplified. The length of 
the DNA products was approximately 1,400 bp, which corresponds to the 
length of the potato sequences. Amplification of the inserted plant sequences 
worked for all clones, except for the first clone picked from the 38025 harbor-
ing plate. 
15010 25760 38025 - control 1,200 bp 
1,500 bp 
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In most cases multiplex PCR (uses more than one primer pair) is less efficient than sin-
gleplex. In order to obtain best sensitivity only one pair of primers should be added to 
an assay. Therefore plant DNA had to be amplifiable applying bacterial primers. Thus 
adapter primers were introduced which contained the plant primers flanked by bacterial 
primers. The internal control sequences were amplified using these adapter primers 
(see figure 17). The products of this amplification are the plant sequences ligated with 
the sequences for primer 45F and primer 1391R. 
Amplification of the plant DNA with the adapter primers did not work as expected. More 
than one band was observed on the gel. Therefore, a second amplification was per-
formed using the bacterial 16S rRNA specific primers, to support solely amplification of 
already successfully ligated PCR products. After this amplification only a few samples 
showed bands. Further investigation revealed that the bacterial reverse primer se-
quence was linked to the 3’ end of the plant reverse primer. Figure 17 shows the correct 
orientation of each primer sequence. Both, the forward and the reverse primer, require 
the bacterial 16S rDNA specific sequence on the 5’ end of the primer. 
 
In order to control integrity of the plant sequences after several amplification steps, 
they were reamplified using the potato specific primers. This reamplification resulted in 
more than one band on the agarose gel for the 15010 sequence, as shown in figure 18. 
Figure 17: Design of adapter primers. The forward primer (homologous to the 
template strand) is drawn in black while the reverse primer (homologous to 
the coding strand) is drawn in red. The arrow indicates the direction of the 
primer (5’ to 3’) and the dotted line aligned to each primer represents the 16S 
rDNA specific primer sequence. 
5’ 3’ 
5’ 3’ 
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It is very important that the PCR products used as internal control are not a mixture of 
specific and unspecific amplification products. Therefore a DNA stock containing more 
than the specific sequence could not be used for internal control. Thus, a gel extraction 
was carried out with the targeted band cut from the gel and used for PCR product ex-
traction. Subsequently the extracted DNA was initially amplified with the new adapter 
primers and in a following amplification with the bacterial 16S rDNA specific primer pair 
45F and 1391R. Figure 19 shows amplification with the bacterial specific primer pair did 
now work resulting in clearly visible single bands per lane. This indicates a successful 
ligation of the bacterial primer sequences to the plant DNA. 
15010 25760 38025 - control 
1,200 bp 
1,500 bp 
Figure 18: PCR products of amplified plant sequences loaded onto a 1.5% agarose gel. 
Plant sequences were first amplified using the adapter primers and then a second am-
plification was performed using the bacterial primers 45F and 1391R. This product was 
applied for re-amplification with plant primers in order to examine product integrity. 
15010, 25760 and 38025, are the different plant sequences. The 15010 sequence gave 
four distinct bands on the gel. Only the second band from the bottom (indicated with 
an arrow) contained the desired sequence. 
55 
 
Primary amplification with the primers 45F and 1391R worked perfectly, however, a 
subsequent amplification step of the first PCR product using the same primer pair only 
gave very little or no product. A repetition of the PCR did not lead to a solution of the 
problem. Therefore the initial PCR product of the amplification using the adapter pri-
mers was applied as internal control and was spiked into the sample at different work-
ing steps. 
4.2.1.2 16S rDNA of methanotrophic bacteria 
Genomic DNA from different methanotrophic bacteria were thankfully obtained by Le-
vente Bodrossy. 16S rDNA was amplified using the standard primer pair 45F and 1391R. 
Figure 20 shows the PCR products after initial amplification of all sequences. 
15010 25760 38025 
- control 
1,200 bp 
1,500 bp 
Figure 19: Agarose gel showing PCR products of amplified potato sequences 
applying primers 45F and 1391R. Designations 15010, 25760 and 38025 corres-
pond to respective plant sequences. 
Figure 20: Agarose gel showing PCR products of the amplification of me-
thanotrophic bacterial DNA. Abbr.: msz: Methylocaldum szegediense; 
mca: Methylococcus capsulatus (BL-13, BL-5 subgroup, respectively); mtr: 
Methylosinus trichosporium; mag: Methylomicrobium agile 
msz 
mca 
(BL-13) mag - control 
mca 
(BL-5) mtr 
1,200 bp 
1,500 bp 
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The DNA from the methanotrophic bacteria did not need to be sequenced, because 16S 
rRNA sequences of the corresponding species were available in our arb database. 
 
4.2.2 Quantification of internal control DNA 
The ready to use sequences of methanotrophic bacteria and potato were quantified 
using NanoDrop®. The ng/µl (result of NanoDrop) was converted into copy number per 
µl; the formula is noted in the Material & Methods part. NanoDrop® results and calcu-
lated copy numbers per µl are listed in table 4. 
sequence ng/µl (mean of sev-
eral measurements) 
260nm/280nm 
(mean) 
molecular weight 
of dsDNA sequence 
copy number 
per µl 
msz 111 1.85 827,685 Da 8.1*1010 
mca 116 1.86 821,056 Da 8.5*1010 
mtr 100 1.85 793,198 Da 7.6*1010 
mag 101 1.87 824,263 Da 7.4*1010 
15010 18 2.01 753,441 Da 1.4*1010 
25760 20 1.84 732,597 Da 1.7*1010 
38025 20 1.71 727,388 Da 1.7*1010 
 
Dilution series were generated for all internal control sequences, as various concentra-
tions of internal control would be needed in subsequent experiments. Methanotrophic 
DNA was diluted 1/8 to a concentration of circa 1010 copies per µl preceding several 
1/10 dilution steps starting with 109 copies per µl and ending with 101 copies per µl as 
highest dilution. The PCR products of plant DNA already had a concentration of approx-
imately 1010 copies per µl. A 1/10 dilution series was generated for plant PCR products 
starting with approximately 109 copies per µl and ending with 101 copies per µl. 
 
4.2.3 Determination of optimal copy number of internal control 
A certain amount of internal control DNA has to be added to each sample. In case too 
little control DNA is added, the internal control could not be detected on the microarray, 
Table 4: Results of NanoDrop® measurements and calculated copy number per µl of each 
internal control sequence. Each sequence was measured several times and means are 
listed. The molecular weight of each sequence (dsDNA) in Dalton (Da) was calculated using 
BioEdit software. 
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if too much DNA is put into the sample, it could hamper the amplification of the patho-
gen DNA. 
4.2.3.1 Potato DNA 
In order to determine the ideal concentration of internal control per assay a dilution 
series of the internal control originated from potato sequences was again amplified by 
PCR. In some assays a mixture of internal control and pathogen DNA was provided, to 
identify possible obstructive influence of the plant DNA on the amplification of patho-
gen DNA. The results of this experiment are shown in figure 21. 
 
The addition of the internal control originated from plant sequences to the pathogenic 
DNA did not hamper the amplification of any sequence. The detection limit of the plant 
DNA was identified as approximately 100 copies per reaction. In the row of sequence 
38025 a clear band is visible at this concentration, while the band for 15010 at this con-
centration is barely visible. Amplification of 100 copies per µl DNA from the 25760 se-
quence did not work due to unknown problems. However, when comparing the bands 
generated by the PCR products with an initial 103 copies per reaction, they have a simi-
lar intensity for 15010 and 25760 sequences, suggesting that the detection limit for DNA 
from 25760 also is 100 copies per reaction (see figure 21). On the gel internal control 
and E. coli sequences generate two distinct bands, as the amplified plant DNA is slightly 
shorter than the amplified 16S rRNA gene fragment of bacteria. The two bands are es-
pecially visible for coamplified E. coli plus 38025 DNA. For E. coli plus 15010 DNA a slight 
Figure 21: Agarose gel showing plant sequences with and without addition of E. coli 
DNA. 15010, 25760 and 38025: designations of the plant sequences; 102 to 106 cp/µl: 
concentration of initially spiked-in internal control in copy number per reaction. The 
concentration of E. coli DNA always was 107 cells per ml giving a final concentration of 
104 copies per assay. 
 
- control 
E. coli 
 
15010 25760 38025 
15010 + 
E. coli 
25760 + 
E. coli 
38025 + 
E. coli 
102 to 106 cp/µl 102 to 106 cp/µl 102 to 106 cp/µl 102 to 106 cp/µl 102 to 106 cp/µl 102 to 106 cp/µl 
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shift towards a higher electrophoretic mobility is observed with increasing concentra-
tions of 15010 DNA. Two bands or an increasing electrophoretic mobility were not ob-
served for E. coli plus 25760 DNA. However, analysis was difficult as 25760 PCR products 
alone and products of coamplified E. coli plus 25760 DNA were loaded onto two gels and 
only presented side by side for better visualization. 
PCR products were subsequently labeled and hybridized onto the “Sepsis identification” 
chip. Average signal intensities of the bacterial probes did not decline, in samples where 
103 copies of internal control DNA were added (see figure 22). Further E. coli specific 
signal intensities even increased at higher numbers of added plant DNA (e.g. probe eco2 
gave a signal of 32,800 when 104 copies per µl of 15010 DNA were spiked-in while the 
signal was 31,100 when no plant DNA was added). The addition of plant DNA clearly did 
not hamper amplification or hybridization of E. coli DNA. 
 
Table 5 lists signal intensities of plant specific probes at different spike-in concentra-
tions. Except for 25760 a concentration of 102 copies per assay would give satisfactory 
probe signals when only plant DNA was amplified. However, addition of pathogenic DNA 
at a concentrations of 105 copies per assay hampered amplification of plant DNA result-
ing in lower plant specific signals by approximately 50 %. In detail probe iKc1-l gave a 
high signal of 15,000 when 10 cells per assay E. coli were added (to an internal control 
concentration of 103 copies per assay), which dropped to 8,000 when the concentration 
of E. coli DNA is 107 cells per assay. Signal decreases were not that consistent for all 
Figure 22: Influence of different concentrations of plant DNA on signal intensities of 
E. coli specific probes: left graph eco2 and right graph eco3. Signal intensities of eco2 
and eco3 probes do not decrease with increasing concentrations of internal control in 
the sample. The concentration of E. coli DNA in each sample was 107 cells per ml. Signal 
intensities (SI) of E. coli specific probes are plotted on the y-axis. The concentration of 
plant DNA added to each sample is indicated on the x-axis. In the EC designated sample 
no plant DNA was added. 
internal control (designation and concentration) per assay 
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probes (probe iKb3-l shows the highest signal when 105 cells per ml E. coli DNA were 
added). However, there was a clear tendency that plant specific probe signals decrease 
with increasing concentrations of pathogenic DNA. Based on these results and on the 
results of the agarose gel, it was decided to work with a concentration of 103 copies / 
assay of plant DNA in further experiments. 
15010 
E. coli conc. - 101 102 105 
Plant conc. 102 103 104 103 
iKb1-k - 9000 16000 3500 1500 2000 
iKb1-l 3000 13000 19000 2500 5500 2000 
iKb2-k - 3000 4000 3000 3000 - 
iKb2-l 2000 9000 17000 2000 4500 1500 
iKb3-k 3000 10000 12000 3000 3000 2000 
iKb3-l 7500 15000 20000 7000 7000 9000 
25760 
E. coli conc. - 101 102 105 
Plant conc. 102 103 104 103 
iKa1-k - 4500 6000 2000 - 3000 
iKa1-l - 9500 14000 4000 5000 6000 
iKa2-k - 7000 10500 7000 5000 2000 
iKa2-l - 8500 15000 3500 2500 2000 
iKa3-k - - - - - - 
iKa3-l - 9000 15000 14000 7500 5000 
38025 
E. coli conc. - 101 102 105 
Plant conc. 102 103 104 103 
iKc1-k - 800 1500 - - - 
iKc1-l 16000 17000 20000 15000 11000 8000 
iKc2-k 4500 7500 9500 6500 2000 - 
iKc2-l 8000 11000 14000 8000 3000 1000 
iKc3-k 2000 5000 6500 2500 - - 
iKc3-l 4000 9000 10000 5000 1000 - 
 
4.2.3.2 16S rDNA of methanotrophic bacteria 
The dilution series of the quantified PCR products of methanotrophic 16S rDNA was hy-
bridized, to investigate the ideal concentration for detection on the microarray. The de-
tection limit was shown to be approximately 500 to 1,000 copies of DNA per PCR reac-
tion. Subsequently different methanotrophic DNA concentrations were added to PCR 
Table 5: Comparison of internal control probe signals at varying concentrations of 
spiked-in plant PCR product (copies per assay) and pathogenic DNA (corresponding to 
cells per assay). Plant probes: iKa1-k, iKa1-l, iKb1-k etc. Color code: green: fluorescence 
signal intensity of 0-5,000; blue: 5,000-10,000; red: >10,000 
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assays containing pathogenic DNA. After amplification the products were loaded onto 
an agarose gel (figure 23). 
 
Regarding these results the addition of diluted PCR products of methanotrophic DNA 
probably interferes with the amplification of the pathogenic DNA. The band intensity of 
E. coli DNA decreased successively with the addition of higher concentrations of internal 
control DNA. When 107 copies methanotrophic DNA were added to the E. coli DNA, only 
a very small band was observed. In order to confirm specific amplification the PCR prod-
ucts were hybridized onto the microarray. 
These results confirmed that only very little E. coli DNA was amplified, when 107 copies 
methanotrophic DNA were added. In these samples the pathogen specific signals 
dropped significantly to 13,000 for probe eco2 and 11,000 for eco3. Whereas the sam-
ple containing 105 copies of internal control plus 105 cells / assay E. coli DNA, showed 
high E. coli specific probe signals on the microarray (21,000 for probe eco2 and 16,000 
for eco3). Therefore, the concentration of methanotrophic DNA was kept as low as poss-
ible. A concentration of 103 copies per reaction of methanotrophic DNA gave only unsa-
tisfactory signals on the microarray (probe mtr1-L signal intensities ranged from zero to 
4,500). Therefore, 104 copies per assay of internal control were added for further expe-
riments. 
It remains unclear why pathogen specific amplification is stronger inhibited by the addi-
tion of methanotrophic 16S rDNA that by the addition of internal control originated 
from plant DNA. An explanation could be that the primers in use work better for the 
Figure 23: Comparison of amplification efficiency of solely methanotrophic DNA and in 
combination with E. coli DNA. Products were loaded onto an agarose gel. All concentra-
tions (104, 105, 107) are copy numbers per reaction and refer to PCR products of methano-
trophic DNA only. The concentration of E. coli DNA was 105 cells per assay. 
104 105 107 104 105 107 104 105 107 104 105 107 104 105 107 104 105 107 104 105 107 104 105 107 
- control 
E. coli 
 msz +  
E. coli msz DNA mca DNA mtr DNA mag DNA 
mtr +  
E. coli 
mca +  
E. coli 
mag +  
E. coli 
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methanotrophic sequences than for E. coli DNA. This, however, only partially explains 
the drastic decrease of PCR product in samples where 107 copies of methanotrophic 
DNA were added. 
 
4.2.4 Internal control probe evaluation 
Specific probes for detection of each tested internal control were designed using arb 
software package. These probes were assessed for sensitivity as well as specificity to the 
targeted internal control. 
4.2.4.1 Internal control derived from potato DNA 
Several hybridizations confirmed the high specificity of the plant probes. However, some 
probes gave stronger signals than others. 
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Figure 24 shows the results of hybridizations with different concentrations of internal 
control originated from plant DNA. Best signal intensities were obtained by longer 
probes (iKa1-l, iKa2-l, iKa3-l, iKb1-l …) which generated signals up to 20,000 when ampli-
fied without addition of pathogen DNA. Most short probes (iKa1-k, iKa2-k, iKa3-k, ikb1-K 
…) did not give strong signal intensities, especially when spiked to pathogenic DNA at 
high concentrations. Long probes such as iKb3-l, iKa1-l and iKc1-l showed specific signals 
of 9000, 6000 and 8000 when spiked to 105 cells per assay E. coli DNA, respectively. Best 
Figure 24: Evaluation of probes specific for internal control derived from plant DNA. 
The average signal intensities of diverse hybridizations are plotted in column charts. 
Sequence names and concentrations are indicated in the chart title (cp/µl: copy num-
ber per µl). Signal intensities are plotted on the y-axis while each column on the x-axis 
represents one specific probe. Yellow columns represent samples containing only cop-
ies of the internal control DNA. Dark blue columns represent samples of internal con-
trol DNA parallel amplified with E. coli DNA (c=107 cells/assay). 
Plant specific probes 
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signals from short probes were obtained by iKb3-k and iKa1-k, generating signals of 
2000 and 3000, respectively. Short probes specific for 38025 gave no signals at all, when 
spiked to high concentrations of E. coli DNA. It was expected for longer probes to gener-
ate higher signals, as annealing efficiency correlates with the length of the complemen-
tary sequences. However, this makes longer probes also more susceptible to generating 
unspecific signals. Therefore, both longer and shorter probes were designed. All internal 
controls deriving from plant sequences were targeted by at least one highly specific 
probe which also generated high signal intensities. These were probes iKb3-l for 15010, 
iKa1-l and iKa3-l for 25760 and iKc1-l for 38025. Therefore, all three plant sequences 
were qualified as internal control and were utilized in further experiments. 
4.2.4.2 Internal control derived from methanotrophic bacteria 
Several hybridizations were accomplished, in order to select probes specific for the DNA 
of targeted methanotrophic bacteria. The results of these hybridizations are listed in 
table 6. 
Species name of probe specific unspecific no signal 
Methylocaldum  
szegediense / 
16S rDNA 
msz1     
msz2     
msz3     
msz1-L     
msz2-L     
msz3-L     
Methylococcus  
capsulatus / 
16S rDNA 
mca1     
mca2     
mca3 +   
mca1-L     
mca2-L     
Methylosinus  
trichosporium / 
16S rDNA 
mtr1     
mtr2     
mtr3 +   
mtr1-L +++   
mtr2-L     
mtr3-L     
Methylomicrobium 
agile / 
16S rDNA 
mag1     
mag2     
mag3     
mag1-L     
mag2-L     
mag3-L     
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As indicated in table 6 most probes gave no or unspecific signals. High specific signals 
were only obtained by probe mtr1-L. Some probes did not give any signals. This might 
derive from low PCR efficiency for these sequences, although the primers match well 
with the targeted sequence in the methanotrophic 16S rDNA gene. The PCR products 
loaded onto an agarose gel (figure 23) showed low amplification efficiency for 
M. szegediense, whose specific probes did not generate any signals. M. agile specific 
probes did give unspecific or even no signals. However, the agarose gel revealed good 
performance of sequence amplification. The bad performance of most methanotrophic 
specific probes might be a combination of low PCR efficiency (especially for 
M. szegediense) maybe due to bad working primers or other PCR related amplification 
problems and problems with the probes itself. 
Figure 25 shows the results of the microarray analysis of methanotrophic specific 
probes. This figure demonstrates high numbers of cross-hybridization of many methano-
trophic specific probes. Even the negative control sample (figure 25 D) generated un-
specific signals from five methanotrophic probes. These probes gave strong signals in-
dependently of DNA present in the sample, making them not applicable as internal con-
trol probes. Other probes gave signals when methanotrophic bacteria DNA was in the 
sample, independent of the species (e.g. mag3-L). 
Only three probes generated specific signals. Probes mtr3 and mca3 showed relatively 
low specific signals of approximately 9,300 each. Only probe mtr1-L generated a high 
specific signal (32,800). Addition of internal control to the samples at a concentration of 
104 copies / assay did only slightly hamper amplification of pathogenic DNA (see chapter 
4.2.3.2: 16S rDNA of methanotrophic bacteria). Based on hybridization results the inter-
nal control deriving from M. trichosporium seemed to be best suited and was therefore 
applied for further experiments. 
Table 6: Results of different hybridizations for the assessment of methanotrophic 
probe specificity. Quantified PCR products (dilution series) of methanotrophic 16S 
rDNA were PCR amplified, labeled and hybridized to the “Sepsis identification” chip. 
The products of the PCR amplification were also loaded onto an agarose gel (figure 23). 
Some probes (such as mca1 or mtr1) gave unspecific signals and are indicated in col-
umn unspecific. Column no signal highlights probes that did not give any signals. “+” 
indicates low specific signals, “+++” indicates high and specific signals. 
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4.3 Comparability of internal control probe signals 
In order to investigate the probe specificity and reproducibility of internal control 
probes, several hybridizations of pathogenic DNA coamplified with internal control DNA 
in one sample were carried out. The mean values from two different hybridizations are 
plotted in figure 26. 
It is difficult to compare the results of different hybridizations as the signal intensities 
are subject to considerable fluctuations. It was the aim to make these values compara-
ble by normalizing them with the internal control and thus enabling semiquantitative 
analysis. 
Figure 25: Results of microarray analysis. The DNA of different pathogens was amplified 
together with the methanotrophic PCR product, followed by a hybridization on the “Sep-
sis Pathogen Identification” chip. A: M. trichosporium DNA was spiked to P. aeruginosa 
DNA; B: M. szegediense was spiked to E. coli DNA; C: M. capsulatus internal control DNA 
was spiked to E. coli DNA; D: negative control hybridized to the chip. Signal intensities 
(SI) are drawn on the vertical axis, while probes are plotted on the horizontal axis. Me-
thanotrophic species and corresponding probe names are listed in table 6. Yellow bars 
are signals generated from specific probes, used as control probes. Green bars are spe-
cific probe signals. Red bars represent unspecific signal values. 
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Figure 26: Evaluation of internal control probes of different hybridizations. A dilution 
series of E. coli (EC) and P. aeruginosa (PA) was spiked with internal control DNA, PCR 
amplified and hybridized onto the “Sepsis Identification” chip. The ideal concentration 
of control DNA was previously determined (103 copies per µl and assay). Different 
colors represent different pathogen DNA concentrations as indicated in the chart le-
gend. 
A 
B 
C 
D 
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Figure 26 A and B show internal control 15010 spiked to dilutions of E. coli and 
P. aeruginosa DNA, respectively. Plant specific signal intensities decreased with increas-
ing concentrations of pathogenic DNA present in the sample. For example a sample con-
taining 103 cells per ml E. coli DNA additionally to the plant sequence (103 copies per 
assay), generated an iKb2-l signal of ~16,400 while in the sample containing 105 cells per 
ml E. coli DNA the iKb2-l signal was only 9,500. However, the decrease of plant specific 
signal intensities with increasing concentrations of pathogen DNA was less distinct for 
samples containing E. coli DNA than it was for P. aeruginosa samples. 
While amplification of both species worked equally well (both species still showed bands 
on the gel when 104 cells / ml were amplified, but none when 103 cells / ml were ampli-
fied), the probes specific for E. coli generated much higher signals than the 
P. aeruginosa specific probes. Therefore, the detection limit is higher for E. coli than for 
P. aeruginosa DNA, allowing the detection of only 103 cells / ml E. coli. 
15010 specific probe signals were a little less when the internal control was spiked to 
P. aeruginosa DNA than to E. coli DNA. The values for probe iKb1-l were 9,300 when 
spiked to 104 cells / ml P. aeruginosa but 11,600 when spiked to the same concentration 
of E. coli DNA. It was the other way round with 38025 specific probes. These probes 
generated surprisingly strong signals when the internal control was spiked to 104 cells / 
ml P. aeruginosa DNA. Signals of probes iKc1-l and iKc2-l were 25,000 and 13,300 when 
spiked to P. aeruginosa and 17,200 and 9,400 when spiked to the same amount of E. coli 
DNA. 
Probes with small standard deviation values are better comparable and more reliable 
than probes with a high standard deviation. The ideal internal control probe generates 
relatively high, specific signals and shows fluctuations comparable to those from patho-
gen specific probes. These features are important for an internal control to enable se-
miquantitative analysis in microarray experiments. 
Generally it was shown that standard deviation of mean probe signal intensities over 
several hybridizations relative to the signal intensity was lowest for long internal control 
probes. Especially probes iKb1-l, iKb2-l, iKc1-l and iKc2-l showed low average values of 
31 %. Considerably higher were fluctuations of pathogen specific probes (49 % in aver-
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age) and short internal control probes (esp. iKb3-k, iKc2-k) generated the highest stan-
dard deviation values relative to their mean signal intensities (55% in average). 
For the 15010 sequence, probe iKb1-l was most suitable as internal control, followed by 
probe iKb3-l. For the 38025 sequence, probe iKc1-l worked best, followed by probe 
iKc2-l. This choice was confirmed by the mean signal intensities of all hybridizations (in-
dependent of pathogen species and concentrations). Based on all results, probe iKc1-l 
seemed to be the best internal control probe, as it provides high specific fluorescence 
(mean of all hybridizations is >18,000) and, compared to other probes, showed rather 
low fluctuations (standard deviation relative to signal intensity <20 %). 
 
4.4 DNA Isolation from whole blood 
Proper bacterial DNA Isolation from whole blood is one of the most important steps for 
the detection of pathogens with sufficient sensitivity and specificity. Several methods 
were tested by Herbert Wiesinger-Mayr. One of the best working assays, although rela-
tively work intensive, was the MolYsis Kit from Molzym. Therefore, this kit was tested 
for the recovery of bacterial DNA as well as internal control DNA from whole blood 
samples. Bacterial cells were spiked to fresh whole blood, while the internal control DNA 
was added just before pathogen cell lysis. Bacterial DNA isolation worked well in com-
parison to isolations from pure culture, when the protocol was carefully followed. After 
PCR amplification a relatively small concentration of bacterial DNA could be detected on 
the gel (figure 27). 
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After microarray analysis of the DNA isolates, high E. coli specific signals were detected. 
However, the specific signals of internal control derived from plant DNA were relatively 
low. This might be caused by a partial loss of the DNA during the isolation process from 
whole blood or by an interference of the high background of human DNA in subsequent 
PCR and labeling reactions. However, low specific signals can partially be compensated 
by increase of pmt (photomultiplier transmission) during the scanning process. Figure 28 
shows the microarray analysis results of different samples. 
E. coli DNA (104 cells/ml) 
+ mtr + 15010 + 25760 + 38025 
104 10
5 103 103 103 104 104 104 
- control 
+ control 
1,200 bp 
1,500 bp 
Figure 27: Agarose gel after electrophoresis of PCR products obtained by amplifica-
tion of bacterial and internal control DNA. E. coli cells were spiked to whole blood in 
a final concentration of 104 cells per ml blood. Plant derived internal control DNA 
was added in concentrations of 103 and 104 copies per ml blood while mtr internal 
control was added in concentrations of 104 and 105 copies per ml blood. Abbr.: mtr: 
M. trichosporium; 15010, 25760 and 38025 indicate the different plant internal con-
trol sequences; positive control sample: E. coli DNA (c=107 cells per µl) isolated from 
pure culture. 
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Figure 28 shows that the microarray signals for E. coli specific probes were rather high. 
Interestingly, M. trichosporium internal control probe signals were high as well (12,000), 
although the probe signals for all three plant sequences (iKa1-3, iKb1-3 and iKc1-3) were 
quite low. By spiking 103 copies of plant internal control DNA to 104 cells per ml E. coli 
DNA isolated from pure culture and subsequent PCR amplification, high specific signals 
were obtained after microarray analysis. Important plant specific probes iKb1-l, iKb3-l 
and iKc1-l generated signals of 11600, 13300 and 17200, respectively (see figure 26). 
However, when 104 copies internal control DNA were spiked to whole blood along with 
E. coli cells (c=104 cells per ml blood) only little plant specific signals could be detected 
on the microarray. Specific signal values were zero from probe iKb1-l (decline is 11600), 
5800 from iKb3-l (decline of 7500) and 5000 from iKc1-l (decline of 15200). This clearly 
indicated that a huge amount of internal control DNA got lost during isolation from 
whole blood. No big differences were observed for pathogen specific signal intensities 
Figure 28: Results of microarray analysis. Whole blood was spiked with E. coli, and 
internal control DNA was added just before bacterial cell lysis. Then the pathogenic  
and internal control DNA was isolated from blood, PCR amplified and analyzed with 
the “Sepsis Identification” chip. A: M. trichosporium 16S rDNA was spiked to whole 
blood; B: 15010 internal control DNA was spiked to blood; C: 25760 DNA was spiked to 
and recovered from blood; D: 38025 internal control DNA was spiked to whole blood. 
On the vertical axis the signal intensities (SI) of the single probes obtained by microar-
ray analysis are plotted. The horizontal axis shows the probe names. Color code: yel-
low: control probes for successful protocol realization; green: pathogen specific 
probes; red: unspecific signals 
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between DNA isolation from pure culture (signal of probe eco2 was 20,100) or from 
whole blood (mean signal intensity was 15,400 for eco2), however. The loss of internal 
control during DNA isolation from whole blood might be caused by the column purifica-
tion of DNA included in the MolYsis kit. These columns are specialized for the isolation 
of bacterial genomes which are typically well above 5 million bases in length. The inter-
nal control sequences, however, are only approximately 1,400 bp long and therefore, 
might not attach to the column as efficiently as longer sequences. 
 
4.5 Quantification by Real-time PCR 
In order to confirm the semiquantitative data obtained by microarray analysis a real-
time PCR protocol was established. Several considerations have to be made for intro-
ducing a well working protocol, which allows the quantification of unknown samples. 
The primer pair should amplify a target fragment shorter than 150 bases and should not 
show runs of identical nucleotides. Furthermore, melting temperature (Tm) values of 
the primers should lie between 58 and 60°C and complementarities within or between 
primers should be avoided [Applied Biosystems, Real-Time Tour 2008]. Primer se-
quences used in this work are listed in table 11 in Appendix 1. The ideal primer concen-
tration was determined to be 900 nM. Finally a reliable and distinct standard curve 
needs to be established for a successful quantification of unknown targets. The standard 
curve ideally amplificates with high efficiency and covers a wide range of concentra-
tions. 
 
4.5.1 Selection of primer pair 
Different primer pair combinations were tested in order to select a good working primer 
pair for use in real-time PCR. All primer pairs were specific for the 16S rRNA gene of bac-
teria.  
Real-time PCR efficiency is optimal when the amplified sequence is shorter than 200 bp 
(base pairs) because the ability of PCR product doubling increases with decreasing am-
plification length. Therefore a good working primer pair needs to be selected. 
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Different primer pair combinations were tested in a normal PCR and the products ana-
lyzed by agarose gel electrophoresis. Selected results are listed in table 7. 
forward primer reverse primer amplicon length PCR efficiency 
8F 1491R 1,483 bp ++ 
45F 1391R 1,346 bp +++ 
45F 154R 109 bp + 
45F 316R 271 bp ++ 
347F 514R 167 bp + 
347F 673R 326 bp +++ 
521F 673R 152 bp + 
783F 926R 143 bp +- 
916F 1391R 475 bp +++ 
 
In our experiments the amplification of larger fragments, usually worked better, than 
the amplification of smaller sequences. Figure 29 shows that amplification of E. coli and 
S. aureus DNA with the primer pair 347F and 673R (amplicon length is 326 bp) worked 
better than with the primer pair 347F and 514R (amplicon length is 167 bp). However, a 
few primer pairs amplifying smaller fragments were selected for application in real-time 
PCR. 
 
Table 7: List of primer pairs with their respective amplicon lengths and amplification 
efficiencies. “+++”: excellent amplification; “++”: good amplification; “+” acceptable am-
plification; “+-“: bad amplification 
Figure 29: Agarose gel showing PCR products amplified with different primers. A DNA 
dilution series of 107 cells/ml to 103 cells/ml of Escherichia coli (E. coli) and Staphylococ-
cus aureus (S. aureus) DNA were amplified using Taq Polymerase mix (Invitrogen) and 
primer pairs 347F and 514R, 347F and 673R, respectively. + control: Enterococcus fae-
cium DNA (108 cells/ml); - control: water control 
107 106 105 104 103 107 106 105 104 103 
E. coli S. aureus 
- control 
+ control 
107 106 105 104 103 107 106 105 104 103 
E. coli S. aureus 
- control 
+ control 
primers 347F and 673R primers 347F and 514R 
200 bp 
300 bp 
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Some negative control samples showed bands in the gel (figure 29). To overcome this 
problem, several PCR mixes (Taq Polymerase from Invitrogen, ImmoMix Red from Bio-
line and Molzym 16S basic from Molzym) were tested. Amplification with the ImmoMix 
resulted in huge amounts of PCR product as visualized by gel electrophoresis (data not 
shown). However, severe problems concerning contamination of negative control sam-
ples were encountered. PCR applying the Taq Polymerase Mix and the Molzym mix 
showed an equal efficiency of amplification. As seen in figure 29, amplification with the 
Taq Polymerase mix also showed slight bands in negative control samples. As no prob-
lems concerning the negative control were observed with the Molzym mix, this PCR mix 
was used for amplification of DNA in further experiments. 
 
4.5.2 SYBR® Green PCR Master Mix 
SYBR® Green real-time PCR was tested by applying the primer pair 521F and 673R at two 
different concentrations (500 nM and 900 nM). E. coli DNA corresponding to 105 cells 
was added per real-time PCR assay. 
Figure 30 shows threshold cycles of a DNA dilution series. Ct values were lower when 
primers were added at a concentration of 900 nM compared to 500 nM. Average thre-
shold cycle values in samples containing undiluted template DNA were 15.3 for a primer 
concentration of 500 nM and 15.2 for primer concentrations of 900 nM. Bigger differ-
ences were observed in 1/100 diluted samples of the template DNA. The values were 
20.2 and 19.0 for primer concentrations of 500 nM and 900 nM, respectively. Therefore 
a concentration of 900 nM was chosen for further experiments. However, threshold 
cycle differences between single dilution steps of E. coli DNA did not correlate exactly. A 
threshold cycle difference of 1 (or slightly over 1, when PCR efficiency is not 100 %), is 
expected from single ½ dilution steps, as in PCR the DNA amount doubles with every 
cycle. However in some assays the threshold cycle of a ½ dilution was lower than the 
threshold cycle of the original DNA (see figure 30). This indicates that inhibitors of the 
PCR were present in the samples. These results were confirmed in further experiments. 
Threshold cycles between assays were subject to considerable fluctuations. While most-
ly the threshold cycle differences between single ½ dilution steps were zero to 1.8, in 
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extreme cases differences of up to minus 6 cycles were observed between undiluted 
samples and ½ dilutions.  
 
Dissociation curve analysis available for SYBR® Green PCR provided a good indication 
that only the desired fragment was amplified. Unspecific amplification or generation of 
primer dimers is visualized in the dissociation curve by a second peak in the chart. Fig-
ure 31 shows the dissociation curve for real-time PCR applying SYBR® Green and the 
primer pair 521F and 673R in concentrations of 500 nM and 900 nM. Only one peak can 
be seen in this dissociation curve, thus revealing specific amplification of primer pair 
521F and 673R. 
Figure 31: Graph of SYBR® Green real-time PCR dissociation curve. Increasing 
temperatures are drawn on the x-axis, while the derivative of detected fluo-
rescence intensity is drawn on the y-axis. 
Figure 30: Results of real time PCR experiment with primer pair 521F and 673R at con-
centrations 500 nM and 900 nM. The x-axis shows applied dilutions of the original 
DNA (indicated as 1) on a logarithmic scale. Threshold cycles (Ct) are drawn on the y-
axis. 
1/2 
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4.5.3 TaqMan® Universal PCR Master Mix 
Real-time PCR using TaqMan® probes was compared to SYBR® Green assays. However, 
as the results were not better than in real-time PCR applying SYBR® Green, it was settled 
on the SYBR® Green PCR Master Mix (Applied Biosystems) for further experiments. A 
dilutions series of S. aureus DNA (starting concentration corresponding to 105 cells) was 
generated and amplified using both real-time PCR assays. Threshold cycles were 
reached 7 cycles later with the TaqMan® mix on average. For example the 1/20 dilution 
of the template DNA had a threshold cycle of 20 when amplified with SYBR® Green but 
of 27 when amplified with the TaqMan® mix. This might be due to the fact that only one 
TaqMan probe (only one fluorophore) is present per strand of dsDNA, while multiple 
copies of SYBR® Green bind. Therefore, later threshold cycles in TaqMan® PCR do not 
necessarily mean that it did not work as well as SYBR® Green real-time PCR. 
 
4.5.4 Generation of a standard curve for quantification 
By relating threshold cycles of unknown samples to a standard curve, quantification is 
possible. A good standard curve was obtained by establishing a ½ dilution series of 
M. trichosporium PCR products (see figure 32) and amplification with the SYBR® Green 
real-time PCR mix. In these high diluted samples, no PCR inhibitory substances were 
present, which enabled efficient amplification of target DNA. However, the 16S rRNA 
sequences of methanotrophic bacteria are slightly different from human pathogens like 
E. coli and S. aureus. The previously applied primer pair 521F and 673R, therefore did 
not work with DNA from M. trichosporium. Primer pair 521F and 764R was selected for 
real-time PCR experiments amplifying DNA from methanotrophic bacteria. 
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The standard curve of figure 32 can be used for quantification. The distance between Ct 
values of single dilution steps is 1.124 (see formula in figure 32), which means that the 
DNA is doubled every 1.124 cycles (corresponding to an efficiency of 95.5 %). A factor of 
1 would mean that the amplification was 100 % effiecient, which is almost impossible to 
reach in real-time PCR [Applied Biosystems, Real-Time Tour 2008]. For quantification the 
R squared value should be above 0.9. In out experiments this value was 0,995. 
Although the qualitiy of the standard curve was sufficient (confirmed by the R squared 
value), a quantification of target DNA was not possible. The sample DNA was obtained 
by lysis of bacterial cells from pure culture or from whole blood followed by purfication. 
There were still PCR inhibitory substances in these samples which prevented a reliable 
amplification and therefore a quantification. 
 
4.6 Assessment of bacterial viability 
DNA cannot be used as target for the assessment of bacterial viability, since in actively 
killed cells the DNA persists and can be detected for long periods of time [Masters et al., 
1994]. RNA, especially mRNA is the better target for analyzing bacterial viability [Keer 
and Birch, 2003]. Several methods for the amplification of 16S rRNA and different mRNA 
Figure 32: Standard curve obtained by the amplification of a ½ dilution series applying 
the primer pair 521F and 764R at a concentration of 900 nM. Template DNA: PCR 
product of M. trichosporium DNA quantified by NanoDrop®, diluted to concentrations 
from 100,000 to 12,500 copies per µl. One µl of DNA suspension was added per assay. 
A trendline was applied to the standard curve in order to determine the slope and R² 
value of the curve 
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targets were tested. The best method would be integrated into the sepsis chip protocol, 
to be able to directly detect RNA on the chip. The calculations of ratios between DNA 
and RNA would allow the discrimination between alive and dead bacteria. 
 
4.6.1 Superscript III Reverse Transcriptase and AMV Reverse Transcriptase 
Superscript reverse III transcriptase (Invitrogen) did only work when high amounts of 
target RNA were used, as visualized by gel electrophoresis. Similar results were obtained 
by Avian Myeloblastosis Virus reverse transcriptase (AMV-RT). In both cases, the prod-
ucts of the reverse transcription reaction were added to a PCR to amplify the previously 
generated cDNA. Figure 33 shows the results of Superscript III and AMV-RT amplification 
of RNA. On the gel it can be seen that Superscript reverse transcription worked slightly 
better (stronger band in the 1/50 dilution sample) than AMV-RT. 
 
4.6.2 Omniscript Reverse Transcription (Qiagen) 
Omniscript reverse transcription followed by PCR, also worked with low amounts of 
template RNA. Purified RNA equivalent to 105 cells was added per Omniscript reverse 
transcription assay. After the subsequent PCR the products were loaded onto a gel lead-
ing to thick bands (figure 36). Also after hybridization high pathogen specific signals 
were detected on the microarray. Therefore Omniscript reverse transcriptase (Qiagen) 
was considered to work better than Superscript reverse transcriptase (Invitrogen) and 
AMV-RT (Invitrogen) in terms of sensitivity. Omniscript reverse transcription was then 
further applied for positive control samples for the experiments based on nucleic acid 
sequence-based amplification (NASBA). 
Figure 33: Products of Super-
script III RT and AMV-RT followed 
by PCR loaded onto 1.5% agarose 
gel. 1/5, 1/10 and 1/50: dilutions 
of E. coli RNA (initial conc. corres-
ponding to 105 cells). 
E. coli RNA E. coli RNA 
1/5 
1/10 
1/50 
1/5 
1/10 
1/50 
- control 
- control 1,200 bp 
1,500 bp 
Superscript RT AMV-RT 
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4.6.3 Nucleic acid sequence-based amplification (NASBA) 
4.6.3.1 Home-made NASBA 
NASBA was carried out following the protocol by Song et al., 2000. Subsequent to the 
NASBA reaction no PCR was needed, as in NASBA an amplification of the target RNA is 
accomplished. However, the NASBA reaction did not perform with sufficient efficiency. 
Because of the necessary activity of three enzymes in NASBA, there are several factors 
that can inhibit or hamper the reaction. A lot of parameters were changed during troub-
leshooting. First the functionality of two out of the three enzymes was tested using the 
primers T7-8F and 1391R. The AMV-RT (Invitrogen) was tested by reverse transcribing a 
RNA template followed by a PCR reaction to amplify the cDNA (the results can be seen 
in part 4.6.1 of the results section). Then the T7 polymerase (Roche) was tested by rea-
lizing an in vitro transcription reaction. The template DNA needed to harbor the T7 pro-
moter sequence. Therefore a PCR was performed applying the primer pair T7-8F and 
1391R, which ligated the T7 sequence to the amplicon. The diluted PCR product was 
then added as template DNA to the in vitro transcription reaction. The results of this in 
vitro transcription can be seen in figure 34. 
 
Figure 34 shows that the in vitro transcription worked. However, the products do not 
form one distinct band, but a smear, indicating that the RNA was degraded either before 
or during the running of the gel. The activity of the RNase H (New England Biolabes Inc.) 
was not tested individually. 
1,200 bp 
1,500 bp 
1 2 3 4 5 Figure 34: T7 in vitro transcription 
products loaded onto a 1.5 % aga-
rose gel. Template DNA: E. coli RNA 
reverse transcribed into cDNA and 
subsequently PCR amplified applying 
primers T7-8F and 1391R. Lane 1 
and 3: 1 µl of template DNA was 
added into the reaction; lane 2 and 
4: 5 µl of template DNA were used; 
lane 5: negative control sample 
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During the next step the efficiency of the NASBA buffer was determined. An Omniscript 
reverse transcription reaction was carried out using the buffer prepared for the NASBA 
reaction instead of the typically used buffer RT (Qiagen). The reverse transcription ap-
plying the NASBA buffer did work, although not as efficiently as with the buffer deli-
vered by Qiagen for reverse transcription. Distributed buffers have to pass extensive 
performance tests before they are sold. Therefore, it was expected that purchased 
ready-to-use buffers work better than home-made ones. Plus, the NASBA buffer does 
not only have to provide the optimal environment for reverse transcription but also for 
in vitro transcription and RNase H mediated reactions. 
4.6.3.2 NASBA applying the NucliSENS EasyQ® Basic Kit v2 (Biomérieux) 
The home-made NASBA mixture was compared to the efficiency of the commercially 
available NASBA kit from Biomérieux. When the NASBA products were directly loaded 
onto the gel no bands were observed. However, after a subsequent PCR bands on the 
gel were visible. Therefore, it was considered that the reverse transcription reaction in 
NASBA did work, but at a very low sensitivity. One possible explanation was that the T7 
promoter sequence was not or wrongly aligned to the target sequence. 
The NASBA reaction applying a new set of primers together with the Biomérieux kit gave 
bands on the gel (see figure 35). Although the bands appear to be blurry, they did mi-
grate with the correct electrophoretic mobility. The products of the primer pairs 45F and 
317R_T7, 45F and 673R_T7, 45F and 1391R_T7 were expected to be 272 bp, 628 bp and 
1346 bp in length, respectively (see figure 35 A). After a subsequent PCR the samples 
gave strong and clear bands. 
In figure 35 B a dilution series of S. aureus RNA was amplified by NASBA. Also during this 
experiment blurry bands were obtained. The single dilution steps are identifiable, ex-
cept the 1/1,000 dilution gave a stronger band, than the 1/100 dilution step. Also the 
sequences were migrating with the correct electrophoretic mobility, as expected for a 
product of the primer pair 347F and 673R_T7, which is 326 bp in length. 
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Also in subsequent experiments the products of the NASBA reaction gave always blurry 
bands. NASBA applying the NucliSENS EasyQ® Basic Kit v2 did work, however, RNA am-
plification applying other methods such as reverse transcription followed by PCR gave 
better results. 
 
4.6.4 OneStep RT-PCR (Qiagen) 
Another method for the amplification of RNA is Reverse transcription-PCR (RT-PCR). It 
combines reverse transcription of RNA and amplification of cDNA in one assay, with the 
advantages of speed and a reduced risk of contamination. OneStep RT-PCR from Qiagen 
gave the best results for the amplification of RNA. Also, when only small amounts of 
template RNA were added to the reaction, a lot of product could be detected by gel 
electrophoresis. 
NASBA NASBA + 
PCR 
45F, 317R_T7 
45F, 673R_T7 
45F, 1391R_T7 
45F, 673R_T7 
45F, 1391R_T7 
45F, 317R_T7 
700 bp 
400 bp 
1,500 bp 
- control 
S. aureus 
 
1 2 3 4 5 6 
E. coli RN
A
 
400 bp 
A B 
Figure 35: NASBA products applying the NucliSENS EasyQ® Basic Kit v2 were loaded onto 
1.5% agarose gels. A: new reverse primers 317R_T7, 673R_T7 and 1391R_T7 were tested. 
Products were loaded directly (left) and after a subsequent PCR (right) onto the gel; B: 
NASBA of a dilution series of S. aureus RNA (original concentration corresponds to ap-
proximately 5*107 cells per assay) applying primers 347F and 673R_T7. Numbers 1-6 cor-
respond to dilution steps of a 10 fold dilutions series (10-2 to 10-7, respectively). Undi-
luted E. coli RNA (concentration corresponds to 5*107 cells per assay) was added to a 
positive control sample. The negative control sample showed a band. However, this band 
was extremely blurry and did show an increased electrophoretic mobility compared to 
the other samples. The same effect was observed in the 1/10-7 diluted sample and also, 
less distinct in lane 1, 3 and 4. 
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OneStep RT-PCR was compared to Omniscript reverse transcription followed by PCR 
realized as a two-step assay. The results are shown in figure 36. In order to prevent 
possible DNA amplification the RNA template was DNAse digested prior to RT-PCR. 
 
OneStep RT-PCR worked considerably better than Omniscript reverse transcription fol-
lowed by PCR (see figure 36). The detection limit for OneStep RT-PCR was 103 cells per 
assay for E. coli RNA and 102 cells per assay for S. aureus RNA, as determined in follow-
ing experiments (data not shown). After hybridization of the samples high pathogen 
specific signals were obtained on the microarray (figure 37). E. coli specific probes eco2 
and eco3 generated signals of 13000 and 6600, respectively and S. aureus specific 
probes sar2 and sar3 showed signal intensities of 4200 and 6100, respectively. There-
fore, OneStep RT-PCR was the method of choice for RNA amplification. 
M. trichosporium was added to the sample to evaluate signal intensities of pathogen 
specific probes. The efficiency of every microarray assay can be determined by analyzing 
the signal intensities of the internal control. By normalizing pathogen specific signals 
with the internal control signals, fluctuations between assays are compensated, which 
makes semiquantification possible. However, no signals were obtained on the microar-
ray for mtr specific probes (figure 37). 
- control 
E. coli RN
A
 
S. aureus RN
A
 
E. coli + m
tr 
S. aureus + m
tr 
+ control 
- control 
E. coli RN
A
 
S. aureus RN
A
 
E. coli + m
tr 
S. aureus + m
tr 
+ control 
Omniscript RT + PCR OneStep RT-PCR 
1,200 bp 
1,000 bp 
800 bp 
Figure 36: Comparison of Omniscript reverse transcription followed by PCR and One-
Step RT-PCR. E. coli and S. aureus RNA was added at a final concentration of 105 cells 
per assay. M. trichosporium (mtr) DNA was added in a concentration of 104 copies per 
assay. + control: Highly concentrated E. coli RNA 
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4.6.5 Housekeeping genes 
Since mRNA is a better target for the assessment of bacterial viability than rRNA [Keer 
and Birch, 2003], several primers and probes were designed for diverse housekeeping 
genes. For assessment of a quantification method it is necessary to determine the 
amount of RNA of cultures in different growth phases and calculate the ratio of DNA. 
Housekeeping genes are essential for the survival of the cell and therefore are constant-
ly expressed. That makes the mRNA of housekeeping genes especially interesting for the 
viability status testing of bacteria. 
However, before bacterial quantification applying the mRNA of housekeeping genes is 
possible, several considerations must be kept in mind. Many housekeeping genes do not 
harbor highly conserved regions, making it difficult to identify sequences within these 
genes specific for a wide range of bacteria. This makes the design of probes and primers 
for housekeeping genes exceptionally difficult. An arb database was established, which 
was the basis for specific probe and primer design. Sequences were obtained from the 
NCBI database [http://www.ncbi.nlm.nih.gov] and subsequently loaded into arb. As a 
result of these data analysis different primers and probes were designed. The sequences 
are listed in table 13 in Appendix 1. 
Table 8 lists selected housekeeping genes and names the proteins they encode. 
 
A B 
Figure 37: OneStep RT-PCR amplified E. coli (A) and S. aureus (B) RNA hybridized to the 
“Sepsis Identification” Chip. M. trichosporium RNA was added in a concentration of 
104 copies per assay. On the vertical axis signal intensities obtained by microarray 
analysis are plotted. The horizontal axis shows the probe names. Color code: yellow: 
specific probes for control of successful protocol realization; green: pathogen specific 
probes; red: unspecific signals 
83 
Gene name Encoded protein 
fusA Translation elongation factor G 
leuS Leucyl-tRNA synthetase 
pyrG CTP synthase 
recG ATP-dependent DNA helicase 
glpK Putative glycerol kinase 
gyrB DNA gyrase subunit B 
 
The DNA of housekeeping genes was amplified to test for specificity of primers and 
probes. Figure 38 shows the products of this amplification loaded onto a 1.5 % agarose 
gel. 
 
Most primers for housekeeping genes were specific for one product and thereby only 
showed one band on the gel (figure 38). Although a few primer pairs generated several 
bands, the band with the correct electrophoretic mobility is always the most prominent 
one (in figure 38, indicated by an arrow). Best working primer pairs were specific for the 
genes fusA, pyrG, glpK and gyrB and did only show a single band per lane. Therefore 
these genes with corresponding primers were considered best suited for quantification 
Nr Species Pr Fw Pr Rev Length 
1 E. coli fusA3f fusA4r ~800 bp 
2 E. coli fusA3f fusA5r ~170 bp 
3 E. coli leuS3f leuS4r ~780 bp 
4 E. coli pyrG3f pyrG4r ~400 bp 
5 E. coli pyrG3f pyrG5r ~150 bp 
6 E. coli recG3f recG4r ~400 bp 
7 S. aureus glpK1f glpK2r ~250 bp 
8 E. coli gyrB1f gyrB1r ~370 bp 
9 E. coli gyrB2f gyrB3r ~775 bp 
10 P. aerugi-
nosa 
gyrB3f gyrB3r ~440 bp 
11 S. aureus gyrB4f gyrB4r ~340 bp 
Table 8: Housekeeping genes and names of encoded proteins. 
Figure 38: PCR products of diverse housekeeping genes. The table on the right side of the 
figure lists the corresponding genes, species and primers to the numbers shown in the gel. 
The expected length of the amplified sequence was compared to the position of the band 
on the gel, to make sure that the primers were specific and only the desired sequence was 
amplified (specific bands are indicated by an arrow). The names of the primers were com-
posed of the abbreviations for the amplified gene, a number and an f for forward primers or 
an r for reverse primers. 
- control 
1 2 3 4 5 6 7 8 9 10 11 
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experiments. Not all primer and probes were specific for all bloodstream relevant pa-
thogens. The specificity is indicated in table 13 in Appendix 1. 
To amplify housekeeping genes of a wide variety of pathogens, a multiplex PCR with 
more than one primer pair would be necessary. In order to amplify gyrase B genes from 
E. coli, S. aureus and P. aeruginosa in one sample, three primer pairs were added. Mul-
tiplex amplification worked almost as well as singleplex PCR. Furthermore, only one spe-
cific band was observed on the gel (figure 39). 
 
To test for the specificity of the designed probes, hybridization with the amplified gy-
rase G gene was performed. With a setup like that the parallel detection of housekeep-
ing RNA for possible viability determination combined with species identification would 
be possible. The results are summarized in table 9. 
Species specificity Name of probe Specific Unspecific No signal 
E. coli 
gB1 eco     
gB2 eco     
gB3 eco +   
S. aureus 
gb1 sau ++   
gb2 sau ++   
gb3 sau +++   
P. aeruginosa 
gB1 pae ++   
gB2 pae +   
gB3 pae     
400 bp 
372 bp 338 bp 
440 bp 
- control 
E. coli 
S. aureus 
P. aeruginosa 
Figure 39: Multiplex PCR amplification of gy-
rase B genes from E. coli, S. aureus and 
P. aeruginosa applying primers gyrB1f and 
gyrB1r, gyrB3f and gyrB3r, gyrB4f and gyrB4r. 
The lanes in this gel correspond to lanes 8, 11 
and 10 in figure 38. 
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Most probes for the gyrase G gene were specific. However, they did not deliver very 
high fluorescence signals on the microarray at the adjusted pmt level of 500. 
A real-time PCR was performed amplifying housekeeping genes. In a first approach only 
the DNA was amplified. This experiment only evaluated the quality of the primers but 
had no significance for quantification approaches and determination of viability status, 
as this would require the amplification of RNA. Figure 40 shows that the amplification of 
fusA, pyrG and leuS genes worked fine as the threshold fluorescence was reached at 
cycles 20.0, 20.7 and 26.7, respectively. The primers for glpK did not work, however. A 
threshold cycle of 40 means that the threshold fluorescence was not reached. 
 
For the use of housekeeping genes in quantification and viability determination, proto-
cols need to be established for microarray analysis of RNA and for real-time PCR amplifi-
cation of RNA.  
Table 9: Results of the hybridization of amplified gyrase G gene. Probes specific for 
the gyr G gens of E. coli, S. aureus and P. aeruginosa were tested. Signal intensities of 
specific probes were indicated with “+” (specific signal), “++” (good signal intensity) 
and “+++” (high specific signals). Probes generating unspecific signals or no signals at 
all were indicated in corresponding columns. 
Figure 40: Results of real time PCR amplification of housekeeping genes. Threshold 
cycles are plotted on the y-axis. The lower the threshold cycle, the better did the 
amplification work. To highlight this, cycles from the threshold cycle to the maximal 
cycle number of 40, are also drawn but in a lighter color. 16S rDNA of E. coli (blue) 
was plotted as a control, while the housekeeping genes fusA, pyrG, leuS and glpK are 
of red color. EC: E. coli, SA: S. aureus. 
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5. Conclusion 
 
5.1 Establishment of internal control 
Internal control sequences were implemented in the sepsis chip protocol. Some difficul-
ties had to be overcome during the process. Problems with sequencing and amplifica-
tion of the plant DNA could be solved. Another challenge was caused by the methano-
trophic 16S rDNA sequences, because of poor specificity of the probes, which prevented 
most of them from being used as internal control. In order to use these sequences as 
internal control new probes should be designed with sufficient differences in sequences 
to be specific. It might be more promising, however, to focus on the further improve-
ment of the plant internal control. 
After establishment of the internal control, the spike-in of the control sequences just 
before pathogen lysis led to satisfying results after microarray hybridization. Internal 
control sequences are needed for normalization and to control obtained pathogen spe-
cific data, which is the base for semiquantitative analysis of initial DNA concentrations. 
Therefore, signal fluctuations of internal control probe signals are acceptable or even 
desired, if they correspond to fluctuations of pathogen specific probes.  
It proved difficult to normalize the pathogen specific probe signals using the internal 
control. High fluctuations of signals between different experiments were observed for 
both pathogen specific and internal control probes. However, fluctuations in internal 
control signals were not correlated with fluctuations in pathogen specific signals.  
To improve the correlation of different probe signals of experiments, the protocol (es-
pecially DNA isolation, PCR and hybridization reactions) needs to be optimized. Also a 
normalization method should be established, as comparing of probe signals was pre-
viously slow and inefficient. A good normalization method would allow the analysis of 
more data and would therefore produce better results. 
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5.2 Quantification via Real-time PCR 
A real-time PCR protocol was established to confirm the semiquantitative results we 
were planning to obtain by microarray analysis. Initially, some problems were encoun-
tered concerning the reliability and accuracy of the results. 
Some real-time PCR results suggested that with water diluted samples would contain 
more DNA than nondiluted samples, which cannot be correct. A possible explanation 
would be a contamination of the water with bacteria or their DNA, which is unlikely. 
Further testing strengthened the assumption that PCR inhibitory substances in the sam-
ple DNA were the cause of these discrepancies. In diluted samples less inhibitors were 
present, leading to a better PCR amplification. 
Real-time PCR experiments were repeated with highly diluted samples generated from 
PCR products. Due to the high dilution, in these samples very little or even no inhibitory 
effect was observed. Real-time PCR amplification worked more accurate with these 
samples. In order to establish a standard curve, which is necessary for quantification, 
NanoDrop® measurements were used to quantify PCR products. They were subsequent-
ly diluted to 105 copies per µl. Dilution series of these samples were then amplified by 
real-time PCR, giving a reliable standard curve. 
However, quantification of DNA samples isolated from bacterial culture or even from 
whole blood proved to be difficult, due to PCR inhibitory substances. Real-time PCR re-
lated problems were excluded as amplification of highly diluted samples worked well. 
Further DNA isolation and purification protocols need to be tested, in order to eliminate 
PCR inhibitors from the sample DNA and to allow proper quantification. 
 
5.3 Viability status of bacteria 
Due to antimicrobial treatment the viability status of disease causing pathogens may 
vary, especially in patients suffering from multiple infections. In order to determine the 
viability status the focus was concentrated on RNA instead of DNA. RNA is a short-lived 
molecule and is mostly degraded in dead bacteria, while DNA can be detected even af-
ter long periods of time in actively killed cells [Masters et al., 1994]. 
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5.3.1 RNA amplification techniques 
Several RNA amplification techniques were tested in order to find the most efficient 
one. Also a method called nucleic acid sequence-based amplification (NASBA) was intro-
duced, which allows for the isothermal amplification of RNA via the combined actions of 
three enzymes. 
Some problems were solved before establishment of a working NASBA protocol. First, all 
the reagents and enzymes were purchased individually and buffers were self prepared. 
RNA amplification did not work properly with this setting. Therefore, a ready to use 
NASBA Kit from Biomérieux was tested. At the beginning amplification did not work due 
to wrong designed primers. After redesign of the T7 promotor carrying primers, first 
results were observed. However, amplification was still poor and did not reach the sen-
sitivity of PCR. Results could not be improved by optimization during following experi-
ments. 
Other RNA amplification techniques worked better than NASBA. Especially Omniscript 
(Qiagen) reverse transcription followed by PCR and the OneStep RT-PCR Kit (Qiagen) led 
to a strong amplification of target RNA. The OneStep RT-PCR Kit from Qiagen was the 
method of choice for RNA amplification, because amplification worked best and reverse 
transcription and PCR reactions occur subsequently in one tube, which saves time and 
decreases the risk of contamination. 
 
5.3.2 Housekeeping Genes 
Several probes for housekeeping genes were added to the sepsis chip. The RNA of these 
genes is constantly expressed because their products are crucial for cell functioning. This 
makes the mRNA of housekeeping genes especially interesting for quantification and 
determination of the viability status of bacteria. Several primers specific for these genes 
were designed and tested. Also protocols for RNA amplification and multiplex PCR were 
established, making on-chip analysis of housekeeping genes possible. 
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However, for quantification RNA amplification in real-time PCR is necessary. Further-
more, products of reverse transcription could be used as template for real-time PCR. 
Also many commercial kits for reverse transcription real-time PCR are available, but 
were not tested in this work. Such a protocol needs to be established and problems with 
PCR inhibitory substances (see above) need to be overcome in order to allow reliable 
quantification of RNA. 
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8. Appendix 1 – sequences of primers and probes 
8.1 New probes designed for the “Sepsis Identification” Chip 
Specific for methanotrophic bacteria 
Spezies / gene 
Name of 
probe 
Sequence [5’-3’] 
Methylocaldum 
szegediense / 
16S rDNA 
msz1 TTTTTACTCGCCACCCACCGGTTA 
msz2 TTTTTCCGCCTTTCTTCCCCGCTT 
msz3 TTTTTGGTTCCCCAGATGTCAAGACCAG 
msz1-L TTTTTACACTCAAGCTCGCCAGTATCAACTGCCATTCCCAGGTT 
msz2-L TTTTTATCTCTCAAGGGTTCCCCAGATGTCAAGACCAGGTAA 
msz3-L TTTTTTAGAGTTCCCGTCTTTACGCTGGCAACTAGGGACAA 
Methylococus cap-
sulatus / 
16S rDNA 
mca1 TTTTTCACAACAAGGCAGATTCCTACGCATTAC 
mca2 TTTTTCACACTCGAGCCTGACAGTATCCAAT 
mca3 TTTTTCCATGCAGCACCTGTGTCTTGG 
mca1-L TTTTTAGAGTTATCCCCCACAACAAGGCAGATTCCTACGCATTA 
mca2-L TTTTTACCAACTAGCTAATCCGACGTAGGCTCATCTTATTGCGCGA 
Methylosinus tri-
chosporium / 
16S rDNA 
mtr1 TTTTTACTCACCCGTCTGCCACTGAC 
mtr2 TTTTTCCTCTCCCGGACTCTAGATCGCC 
mtr3 TTTTTGAGATTTGCTCCGGGTCACCC 
mtr1-L TTTTTTCAAGTTTCCCTGAGTTATTCCGAACCGAAAGGTACGTT 
mtr2-L TTTTTAGGTTGAGCCTCGGGATTTCACCCCTGACTTAACAAT 
mtr3-L TTTTTATCTCTGACGACCATACCGGACATGTCAAAAGCTGGTAA 
Methylomicrobium 
agile / 
16S rDNA 
mag1 TTTTTATCCCACGCAGGCTCATCTCATA 
mag2 TTTTTTCTATAGGTAATGTCAAGTCTGCCGGGT 
mag3 TTTTTAGAGTTCCCAGCATCACGTGTTGG 
mag1-L TTTTTTATTAGCTTGAGTTTCCCCAAGTTATCCCCCACTACTA 
mag2-L TTTTTTGCTTCTTCTATAGGTAATGTCAAGTCTGCCGGGTATTA 
mag3-L TTTTTGAAAACCTTTATAAAGACCAACGGCTAGTTGACATCGT 
Specific for potato DNA 
15010 
iKc1-k TTTTTTTCTCAGAGTTCCCTCGTGATTGATGG 
iKc2-k TTTTTATGAACGCGGATGACATACTGTACCA 
iKc3-k TTTTTATGGTCCTTTAAGGTGTGGCCACA 
iKc1-l 
TTTTTAAGAATTTAGAGCACGTTCCATAATCTGTTGATAAAGAGATAAATA-
GATT 
iKc2-l 
TTTTTTCTTGACTACTACAAAGTAAATAGCGAGAACCATTAATATATGTAA-
CATAT 
iKc3-l 
TTTTTTTAGTTTTA-
TATTCTTACTCTTGTTAGTTTCATCTTTCCTCGAATTTGCAT 
25760 iKa1-k TTTTTTTCCACTAGTGTCTTGCGGCACT 
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iKa2-k TTTTTTGATGAATCCACTGAGTGCTGACCTAG 
iKa3-k TTTTTAGAGCAAAGACACAGATTTGGCGTGT 
iKa1-l 
TTTTTAACAGTGTTTCGTTGTAATTAACTTTGCTCAATAAGTTTATATAAA-
GAGA 
iKa2-l 
TTTTTAAACAACTAATCTCAAACTTAATCAGTTATAA-
CAAAAAAAGCTCATCTCA 
iKa3-l 
TTTTTAGAGAGATTAGTAAGTAACAACTCATTTTTTGATTAGTGAGTAA-
CAATTA 
38025 
iKb1-k TTTTTGGAGAACCCATTTGTCAAGCATAACTCAAGT 
iKb2-k TTTTTTGAGGTACACACAAGCTGACCCAGA 
iKb3-k TTTTTGGATTCATCCCAACTGCTTTCCATTCA 
iKb1-l 
TTTTTACAAAATACACTTGGTATATAGAAATTTTATTCTAGGGGAGAACC-
CATTT 
iKb2-l 
TTTTTTGTTAGTCTAATGCACGTTGATTTAAGGATATTCTCCAAAAGTTA-
TAATA 
iKb3-l 
TTTTTAATATAGTCATCCAAACATGAACTCTTTTCCAAATAACTTATTTTTA-
GAA 
Specific for housekeeping genes 
Enterobacteriaceae/ 
fusA 
fA1 Gen TTTTTCATGGTTGCAGCGCCGTCATG 
Enterobacteriaceae/ 
fusA 
fA2 Gen TTTTTGAACACCACCAACTGCGCAGT 
Enterobacteriaceae/ 
pyrG 
pG1 Gen TTTTTGCAGGGATTCGATATCACCTACAGTACCG 
Enterobacteriaceae/ 
pyrG 
pG2 Gen TTTTTATTGAGGCCACGGGCTTCAAGA 
S. aureus/glpK gK1 sau TTTTTTGCATCATGTTCAACCCAACCTGA 
Enterobacteriaceae/ 
gyrB gB1 Gen 
TTTTTTTCACCTCRGARGARACCAGYTTGT 
E. coli/gyrB gB1 eco TTTTTGCAGACGAATGGAAACGCCGG 
E. coli/gyrB gB2 eco TTTTTGGAAACGACCGCAATCAGGCCT 
E. coli/gyrB gB3 eco TTTTTCTGATTTCACCTCAGAAGAAACCAGTTTGTT 
K. pneumonia/ gyrB gB1 kpn TTTTTATTTCGCTTTTTTGCTATAGCCCTCTTTGTCC 
K. pneumonia/ gyrB gB2 kpn TTTTTAGTTCGTTCATCTGCTGCTCCACC 
K. pneumonia/ gyrB gB3 kpn TTTTTCGAGTCATCTCACGAGCGCGAC 
K. oxytoca/ gyrB gB1 kox TTTTTACTTCGCTTTTTTGCTGTAACCCTCTTTATCC 
K. oxytoca/ gyrB gB2 kox TTTTTAGTTCGTTCATCTGCTGCTCTACCG 
K. oxytoca/ gyrB gB2 kox TTTTTGGGTCATTTCACGCGCACGAC 
E. cloacae/ gyrB gB1 ecl TTTTTTTGGTCTGTGAGGAGAACTTCGGATCC 
E. cloacae/ gyrB gB2 ecl TTTTTGCCCTGCTTCGCAGAACCG 
E. cloacae/ gyrB gB3 ecl TTTTTTTTTACCCACCACGATTTTCGCGTC 
E. aerogenes/ gyrB gB1 eae TTTTTTTAGTCTGAGAGGAGAACTTCGGATCCG 
E. aerogenes/ gyrB gB2 eae TTTTTGCCCTGTTTCGCAGAGCCG 
E. aerogenes/ gyrB gB3 eae TTTTTTCGATAATTTTGCCGACCACGATTTTCGCAT 
C. freundii/ gyrB gB1 cfr TTTTTAAACCGCCCGCTGAGTCC 
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C. freundii/ gyrB gB2 cfr TTTTTCATCTTGTCGAAACGCGCCTTCTC 
C. freundii/ gyrB gB3 cfr TTTTTTTCGCAAAACCGCCCGCTGA 
P. aeruginosa/ gyrB gB1 pae TTTTTGCGAAGTACTTGCCCATCTCCTGT 
P. aeruginosa/ gyrB gB2 pae TTTTTAGTCACCCTCCACGATGTACAGTTC 
P. aeruginosa/ gyrB gB3 pae TTTTTGCGATTGCGGCCCTGCTT 
S. pneumoniae/ 
gyrB gB1 spn 
TTTTTGACCACTTCGCTATTTCCCAATTTGGTCTT 
S. pneumoniae/ 
gyrB gB2 spn 
TTTTTTTCACTGAAGAGGCGATTGGTAATCTTGAC 
S. aureus/ gyrB gb1 sau TTTTTATCTACAACTTGACGCACTTCAGAATTACCT 
S. aureus/ gyrB gb2 sau TTTTTTCAACCACTGTACGTGCGACTTGTG 
S. aureus/ gyrB gb3 sau TTTTTTCTTCAGGACTTTKACTAGAGCAATCGGCT 
Bacteria/ 16S rDNA 16S uni TTTTTAACGCTTGCACCCTCCGTATT 
 
 
 
8.2 Bacterial 16S rDNA specific primers 
Name Sequence [5’-3’] length 
8F GAGTTTGATCCTGGCTCAG 19 
45F GCCTAWCACATGCAAGTCGA 20 
321F TCCTACGGGAGGCAGCAGT 19 
347F GAGGCAGCAGTRGGGAA 17 
521F GCAGCCGCGGTAATACG 17 
783F AGGATTAGATACCCTGGTAGTCCA 24 
916F GAATTGACGGGGGCCC 16 
154R GTATTAGCTACCGTTTCCAGT 21 
316R GCCGTGTCTCAGTYCCA 17 
514R GCGGCTGCTGGCAC 14 
673R CACCGCTACACVTGGAATTC 20 
764R TGTTTGCTCCCCAYGCTTT 19 
797R GGACTACCAGGGTATCTAATCCTGTT 26 
926R GCTTGTGCGGGCCC 14 
1391R ACGGGCGGTGTGTAC 15 
1491R TACGGYTACCTTGTTACGACTT 22 
T7_8F TAATACGACTCACTATAGAGAGTTTGATCCTGGCTCAG 39 
317R_T7 GCCGTGTCTCAGTYCCATAATACGACTCACTATAG 35 
673R_T7 CACCGCTACACVTGGAATTCTAATACGACTCACTATAG 38 
1391R_T7 ACGGGCGGTGTGTACTAATACGACTCACTATAG 33 
 
 
 
Table 10 lists all probe sequences designed during this work and added to the previously published 
“Sepsis ID” chip. Probes already in use with the preceding chip are listed in Wiesinger et al., 2007. 
Table 11: List of 16S rDNA specific primers used in this work. Primers ending with an F are 
forward primers, while primers ending with an R are reverse primers. Primer names including 
T7 do have the T7 promoter sequence aligned to the 16S rDNA sequence. 
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8.3 Adapter primers 
 
 
 
8.4 Primers specific for housekeeping genes 
Target Specificity Name Sequence [5’ to 3’] Length 
fusA 
Enterobacteriaceae; 
Plesiomonas shigel-
loides 
fusA3f CATCGGTATCAGTGCKCACATCGA 24 
fusA4r CAGCATCGCCTGAACRCCTTTGTT 24 
Enterobacteriaceae fusA5r TAGCCATACCAGACCAGAATGC 22 
leuS 
Enterobacteriaceae; 
Plesiomonas shigel-
loides 
leuS3f CAGACCGTGCTGGCCAACGARCARGT 26 
leuS4r CGGCGCGCCCCARTARCGCT 20 
pyrG 
Enterobacteriaceae; 
Plesiomonas shigel-
loides 
pyrG3f GGGGTCGTATCCTCTCTGGGTAAAGG 26 
pyrG4r GGAACGGCAGGGATTCGATATCNCCKA 27 
Enterobacteriaceae; pyrG5r TGCCCCAGGTCCAGGTCGGTTT 22 
recG 
Enterobacteriaceae; 
Plesiomonas shigel-
loides 
recG3f GGCGACGTTGGCTCMGGKAAAAC 23 
recG4r GGGTGCGGGGGATSGGSGTKGC 17 
glpK S. aureus 
glpK1f AATTGCAGGGGTAGCACAACGTG 23 
glpK2r TGACGTGATTGCCAAACAATTGCGTGA 27 
gyrB 
Enterobacteriaceae; 
gyrB1f GCCTGATTGCBGTBGTHTCC 20 
gyrB1r TACCCTTCAGCGGCAGRATCG 21 
gyrB2f TTYGARTAYGAMATYTGGCGAAACG 25 
P. aeruginosa 
gyrB3r GATYTTRCCCTTSAGCGGCAG 21 
gyrB3f ACCTGAACAACTACATCGARGMCGAA 26 
S. aureus 
gyrB4r TGCGTTCTAGAGTCACGACCAGATTTT 27 
gyrB4f 
ACAGCAATTATATCTATCAAA-
CATGGTGACCTCA 
34 
 
 
Plant se-
quence 
Adapter primer Sequence [5’-3’] Length 
15010 
P45F-15010F-iKb 
GCCTAWCACATGCAAGTCGAA-
CATCCCAATTTGGTTACTGCCCTG 
45 
P15010R-1391R-iKb AGGGGACAATGGACCAACTTCTTCATCACGGGCGGTGTGTAC 44 
25760 
P45F-25760F-iKa 
GCCTAWCACATGCAAGTCGATCCTTAT-
GATGGTGGAGTTTTCCAG 
45 
P25760R-1391R-iKa AAAGCAATTATAGCTCGACAAACAGACGGGCGGTGTGTAC 41 
38025 
P45F-38025F-iKc GCCTAWCACATGCAAGTCGAAtGGGCGCTGCATGTTTCGTG 41 
P38025R-1391R-iKc ACACCTTTGTTGAAaGCCATCCCACGGGCGGTGTGTAC 40 
Table 12: List of adapter primers which were used for the ligation of bacterial primers to plant 
DNA in order to amplify pathogenic and plant DNA together in one assay with only one primer 
pair. 
Table13: List of primers specific for different housekeeping genes. Pathogen specificity is 
also indicated in this table. Most housekeeping genes are not as highly conserved as some 
regions of the 16S rRNA genes, therefore the design of primers specific for a wide variety of 
pathogens was difficult and not always successful. Primers fusA3f, fusA4r, leuS3f, leuS4r, 
pyrG3f, pyrG3r, recG3f and recG4r were designed by Salerno et al., 2007. 
101 
Curriculum vitae 
 
Sabine Weninger 
Paffrathgasse 6/10, 1020 Vienna (main residence) 
Antonigasse 2, 7322 Lackenbach (secondary residence) 
Tel.: +43664/7678789; SabineWeninger@gmx.at 
 
 
Date of birth: March 12, 1984 
Nationality:  Austria 
 
 
Education: 
 Since Oct. 2003: studies in biology at the University of Vienna 
  branch: genetics/ microbiology  
with an emphasis in immunology, molecular medicine and 
biochemistry 
 1998 – 2003: commercial academy in Oberpullendorf, Austria 
 1994 – 1998: secondary modern school Lackenbach, Austria 
 
 
Work experience: 
 July 2006:  Amt der Burgenländischen Landesregierung –  
Abt. 9 Gewässeraufsicht 
 Aug. 2004:  arsenal research 
office occupation 
 Aug. 2001: Kromberg & Schubert GmbH Co. KG 
office occupation 
 
 
Additional skills: 
• Languages: German (first language), English (fluent in written and spoken 
form), Italian (basic knowledge) 
• Programming skills in java and php 
• Microsoft office skills 
• Driver’s licence 
 
